Home
  >  
Section 11

EurekaMag Full Text Articles Chapter 10,733



References:

Pangault, C.; Amiot, L.; Caulet-Maugendre, S.; Brasseur, F.; Burtin, F.; Guilloux, V.; Drenou, B.; Fauchet, R.; Onno, M. 1999: HLA-G protein expression is not induced during malignant transformation. Tissue Antigens 53(4 Pt 1): 335-346
Moreau, P.; Rousseau, P.; Rouas-Freiss, N.; Le Discorde, M.; Dausset, J.; Carosella, E.D. 2002: HLA-G protein processing and transport to the cell surface. Cellular and Molecular Life Sciences: Cmls 59(9): 1460-1466
Urosevic, M.; Willers, J.; Mueller, B.; Kempf, W.; Burg, G.; Dummer, R. 2002: HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas. Blood 99(2): 609-617
Bainbridge, D.; Ellis, S.; Le Bouteiller, P.; Sargent, I. 2001: HLA-G remains a mystery. Trends in Immunology 22(10): 548-552
Bainbridge, D.R.; Ellis, S.A.; Sargent, I.L. 2000: HLA-G suppresses proliferation of CD4(+) T-lymphocytes. Journal of Reproductive Immunology 48(1): 17-26
Torres, M.I.; Moreau, P.; Rouas Freiss, N.; Dausset, J.; Carosella, E.D. 2001: HLA-G today. Inmunologia 20(1): 18-29
Gobin, S.J.P.; Biesta, P.; de Steenwinkel, J.E.M.; Datema, G.; van den Elsen, P.J. 2002: HLA-G transactivation by cAMP-response element-binding protein (CREB). An alternative transactivation pathway to the conserved major histocompatibility complex (MHC) class i regulatory routes. Journal of Biological Chemistry 277(42): 39525-39531
Le Bouteiller, P.; Pizzato, N.; Barakonyi, A.; Solier, C. 2003: HLA-G, pre-eclampsia, immunity and vascular events. Journal of Reproductive Immunology 59(2): 219-234
Le Gal, F.A.; Riteau, B.; Sedlik, C.; Khalil-Daher, I.; Menier, C.; Dausset, J.; Guillet, J.G.; Carosella, E.D.; Rouas-Freiss, N. 1999: HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. International Immunology 11(8): 1351-1356
Riteau, B.; Menier, C.; Khalil-Daher, I.; Martinozzi, S.; Pla, M.; Dausset, J.; Carosella, E.D.; Rouas-Freiss, N. 2001: HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition. International Immunology 13(2): 193-201
Shi-Chunlin; Ma-Kangtao; Zhou-Chunyan 2002: HLA-G3 isoform can inhibit polyclonal NK cytolysis. Zhonghua Weishengwuxue He Mianyixue Zazhi 22(4): 354-357
Carosella, E.D.; Moreau, P.; Aractingi, S.; Rouas-Freiss, N. 2001: HLA-G: A shield against inflammatory aggression. Trends in Immunology 22(10): 553-555
Carosella, E.D. 2000: HLA-G: Foeto-maternal tolerance. Comptes Rendus de l'Academie des Sciences Serie III Sciences de la Vie 323(8): 675-680
Martinetti, M.; Dugoujon, J.M.; Tinelli, C.; Cipriani, A.; Cortelazzo, A.; Salvaneschi, L.; Casali, L.; Semenzato, G.; Cuccia, M.; Luisetti, M. 2000: HLA-Gm/kappam interaction in sarcoidosis. Suggestions for a complex genetic structure. European Respiratory Journal 16(1): 74-80
Grimsley, C.; Mather, K.A.; Ober, C. 1998: HLA-H: a pseudogene with increased variation due to balancing selection at neighboring loci. Molecular Biology and Evolution 15(12): 1581-1588
Uzdovsky, V.V.; Balabolkin, I.I. 2000: HLA-Markers of polyallergy in children with allergic diseases. Pochvovedenie 2: 36-38
Latipova, N.S.; Alyavi, A.L.; Ruzybakiev, R.M.; Daminov, B.T. 2000: HLA-antigens in Uzbek patients with systemic lupus erythematosus. Immunologiya 6: 56-58
Egorova, I.V.; Litovskaya, A.V.; Sidorova, T.I.; Tolkacheva, N.I. 1999: HLA-associated genetic control of immune status in exposure to physical and biological occupational factors. Immunologiya 5: 54-59
Imai, T.; Takakuwa, K.; Ishii, K.; Adachi, H.; Higashino, M.; Kurata, H.; Tanaka, K. 2001: HLA-class i antigens in patients with unexplained recurrent abortion. Journal of Perinatal Medicine 29(5): 427-432
De Maria, A.; Moretta, L. 2000: HLA-class I-specific inhibitory receptors in HIV-1 infection. Human Immunology 61(1): 74-81
Murphy, B.; Krensky, A.M. 1999: HLA-derived peptides as novel immunomodulatory therapeutics. Journal of the American Society of Nephrology: Jasn 10(6): 1346-1355
Schulz, A.S.; Classen, C.Friedrich.; Mihatsch, W.A.; Sigl-Kraetzig, M.; Wiesneth, M.; Debatin, K-Michael.; Friedrich, W.; Müller, S.M. 2002: HLA-haploidentical blood progenitor cell transplantation in osteopetrosis. Blood 99(9): 3458-3460
Radich, J.P.; Gooley, T.; Bensinger, W.; Chauncey, T.; Clift, R.; Flowers, M.; Martin, P.; Slattery, J.; Sultan, D.; Appelbaum, F.R. 2003: HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen. Blood 102(1): 31-35
Maris, M.B.; Niederwieser, D.; Sandmaier, B.M.; Storer, B.; Stuart, M.; Maloney, D.; Petersdorf, E.; McSweeney, P.; Pulsipher, M.; Woolfrey, A.; Chauncey, T.; Agura, E.; Heimfeld, S.; Slattery, J.; Hegenbart, U.; Anasetti, C.; Blume, K.; Storb, R. 2003: HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies. Blood 102(6): 2021-2030
Lobnig, B.M.; Chantelau, E.; Vidgrén, G.; Van Landeghem, A.A.L.; Kinnunen, L.; Tuomilehto-Wolf, E. 2002: HLA-patterns in patients with multiple sclerosis and type I diabetes mellitus: evidence for possible mutual exclusion of both diseases. Diabetes and Metabolism 28(3): 217-221
Kikuchi, S.; Fukazawa, T.; Niino, M.; Yabe, I.; Miyagishi, R.; Hamada, T.; Hashimoto, S.A.; Tashiro, K. 2003: HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands. Human leukocyte antigen. Neurology 60(4): 647-651
Mbawuike, I.N.; Wells, J.; Byrd, R.; Cron, S.G.; Glezen, W.P.; Piedra, P.A. 2001: HLA-restricted CD8+ cytotoxic T lymphocyte, interferon-gamma, and interleukin-4 responses to respiratory syncytial virus infection in infants and children. Journal of Infectious Diseases 183(5): 687-696
Mustafa, A.S. 2000: HLA-restricted immune response to mycobacterial antigens: Relevance to vaccine design. Human Immunology 61(2): 166-171
Butina, E.V.[author, Reprint-Author]; Zaitseva, G.A.[author, Reprint-Author]; Yugov, Yu, I.[author, Reprint-Author]; Karpov, D.A.[author, Reprint-Author]; Matrokhina, O.I.[author, Reprint-Author]; Zhuravlev, V.V.[author, Reprint-Author] 2003: HLA-sensitization: Risk of development, posttransfusion complications, methods of prevention. Gematologiya i Transfuziologiya 48(4): 26-29
Sumitran-Holgersson, S. 2001: HLA-specific alloantibodies and renal graft outcome. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 16(5): 897-904
Salerno-Gonçalves, R.; Lu, W.; Achour, A.; Andrieu, J.M. 1999: HLA-unrestricted killing of HIV-1 gag protein-expressing CD4 T cells by gag-specific CD8 cytotoxic T cells. Aids 13(12): 1583-1584
Duquesnoy, Ré.J. 2002: HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. Human Immunology 63(5): 339-352
Duquesnoy, R.é J.; Marrari, M. 2002: HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes. Human Immunology 63(5): 353-363
Duquesnoy, R.J.; Takemoto, S.; de Lange, P.; Doxiadis, I.I.N.; Schreuder, G.M.Th.; Persijn, G.G.; Claas, F.H.J. 2003: HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival. Transplantation 75(6): 884-889
Duquesnoy, R.J.; Howe, J.; Takemoto, S. 2003: HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients. Transplantation 75(6): 889-897
Morita, M.; Ohneda, O.; Yamashita, T.; Takahashi, S.; Suzuki, N.; Nakajima, O.; Kawauchi, S.; Ema, M.; Shibahara, S.; Udono, T.; Tomita, K.; Tamai, M.; Sogawa, K.; Yamamoto, M.; Fujii-Kuriyama, Y. 2003: HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin. EMBO Journal 22(5): 1134-1146
Vieland, V.J.; Logue, M. 2002: HLODs, trait models, and ascertainment: implications of admixture for parameter estimation and linkage detection. Human Heredity 53(1): 23-35
Williams, J.H.; Daly, L.N.; Ingley, E.; Beaumont, J.G.; Tilbrook, P.A.; Lalonde, J.P.; Stillitano, J.P.; Klinken, S.P. 1999: HLS7, a hemopoietic lineage switch gene homologous to the leukemia-inducing gene MLF1. EMBO Journal 18(20): 5559-5566
Baisden, B.L.; Askin, F.B.; Lange, J.R.; Westra, W.H. 2000: HMB-45 immunohistochemical staining of sentinel lymph nodes: a specific method for enhancing detection of micrometastases in patients with melanoma. American Journal of Surgical Pathology 24(8): 1140-1146
Takehara, M.; Ito, E.; Saito, T.; Nishioka, Y.; Ashihara, K.; Yamashita, S.; Koizumi, M.; Kudo, R. 2000: HMB-45 staining for cytology of primary melanoma of the vagina. A case report. Acta Cytologica 44(6): 1077-1080
Tanaka, Y.; Ijiri, R.; Kato, K.; Kato, Y.; Misugi, K.; Nakatani, Y.; Hara, M. 2000: HMB-45/melan-A and smooth muscle actin-positive clear-cell epithelioid tumor arising in the ligamentum teres hepatis: additional example of clear cell 'sugar' tumors. American Journal of Surgical Pathology 24(9): 1295-1299
Ruefli, A.A.; Smyth, M.J.; Johnstone, R.W. 2000: HMBA induces activation of a caspase-independent cell death pathway to overcome P-glycoprotein-mediated multidrug resistance. Blood 95(7): 2378-2385
Smith, T.J.; Parikh, S.J. 1999: HMC-1 mast cells activate human orbital fibroblasts in coculture: evidence for up-regulation of prostaglandin E2 and hyaluronan synthesis. Endocrinology 140(8): 3518-3525
Chou, W.C.; Chou, M.C.; Lu, Y.Y.; Chen, S.F. 1999: HMDS-promoted in situ amidation reactions of carboxylic acids and amines. Tetrahedron Letters 40(17): 3419-3422
Kisseleva, A.F.; Goryunova, L.E.; Planells, R.; Lafont, H.; Alquier, C. 1999: HMG CoA reductase and LDL receptor genes are regulated differently by 15-ketosterols in Hep G2 cells. Biochemical and Biophysical Research Communications 259(3): 688-694
Gray, D.F.; Bundgaard, H.; Hansen, P.S.; Buhagiar, K.A.; Mihailidou, A.S.; Jessup, W.; Kjeldsen, K.; Rasmussen, H.H. 2000: HMG CoA reductase inhibition reduces sarcolemmal Na(+)-K(+) pump density. Cardiovascular Research 47(2): 329-335
Shavelle, D.M.; Takasu, J.; Budoff, M.J.; Mao, S.; Zhao, X.Q.; O'Brien, K.D. 2002: HMG CoA reductase inhibitor (statin) and aortic valve calcium. Lancet 359(9312): 1125-1126
Sugiyama, S. 1998: HMG CoA reductase inhibitor accelerates aging effect on diaphragm mitochondrial respiratory function in rats. Biochemistry and Molecular Biology International 46(5): 923-931
Kunieda, Y.; Nakagawa, K.; Nishimura, H.; Kato, H.; Ukimura, N.; Yano, S.; Kawano, H.; Kimura, S.; Nakagawa, M.; Tsuji, H. 2003: HMG CoA reductase inhibitor suppresses the expression of tissue factor and plasminogen activator inhibitor-1 induced by angiotensin II in cultured rat aortic endothelial cells. Thrombosis Research 110(4): 227-234
Järvisalo, M.J.; Toikka, J.O.; Vasankari, T.; Mikkola, J.; Viikari, J.S.; Hartiala, J.J.; Raitakari, O.T. 1999: HMG CoA reductase inhibitors are related to improved systemic endothelial function in coronary artery disease. Atherosclerosis 147(2): 237-242
Bourcier, T.; Libby, P. 2000: HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells. Arteriosclerosis Thrombosis and Vascular Biology 20(2): 556-562
Bagga, R.; Michalowski, S.; Sabnis, R.; Griffith, J.D.; Emerson, B.M. 2000: HMG I/Y regulates long-range enhancer-dependent transcription on DNA and chromatin by changes in DNA topology. Nucleic Acids Research 28(13): 2541-2550
Nakamura, Y.; Yoshioka, K.; Shirakawa, H.; Yoshida, M. 2001: HMG box a in HMG2 protein functions as a mediator of DNA structural alteration together with box B. Journal of Biochemistry 129(4): 643-651
Valenta, T.; Lukas, J.; Korinek, V. 2003: HMG box transcription factor TCF-4's interaction with CtBP1 controls the expression of the Wnt target Axin2/Conductin in human embryonic kidney cells. Nucleic Acids Research 31(9): 2369-2380
Shih, H.H.; Xiu, M.; Berasi, S.P.; Sampson, E.M.; Leiter, A.; Paulson, K.E.; Yee, A.S. 2001: HMG box transcriptional repressor HBP1 maintains a proliferation barrier in differentiated liver tissue. Molecular and Cellular Biology 21(17): 5723-5732
Ng, E.H.; Lau, E.Y.; Yeung, W.S.; Ho, P.C. 2001: HMG is as good as recombinant human FSH in terms of oocyte and embryo quality: a prospective randomized trial. Human Reproduction 16(2): 319-325
Ross, E.D.; Hardwidge, P.R.; Maher, L.J. 2001: HMG proteins and DNA flexibility in transcription activation. Molecular and Cellular Biology 21(19): 6598-6605
Zhang, C.C.; Krieg, S.; Shapiro, D.J. 1999: HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected Hela cells. Molecular Endocrinology 13(4): 632-643
Lehtonen, S.; Lehtonen, E. 2001: HMG-17 is an early marker of inductive interactions in the developing mouse kidney. Differentiation; Research in Biological Diversity 67(4-5): 154-163
Dansette, P.M.; Jaoen, M.; Pons, C. 2000: HMG-CoA reductase activity in human liver microsomes: comparative inhibition by statins. Experimental and Toxicologic Pathology: Official Journal of the Gesellschaft für Toxikologische Pathologie 52(2): 145-148
Bustos, C.; Hernández-Presa, M.A.; Ortego, M.; Tuñón, J.; Ortega, L.; Pérez, F.; Díaz, C.; Hernández, G.; Egido, J. 1998: HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. Journal of the American College of Cardiology 32(7): 2057-2064
Yang, Z.; Kozai, T.; van der Loo, B.; Viswambharan, H.; Lachat, M.; Turina, M.I.; Malinski, T.; Lüscher, T.F.; van de Loo, B. 2000: HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins. Journal of the American College of Cardiology 36(5): 1691-1697
Lefer, D.J.; Scalia, R.; Jones, S.P.; Sharp, B.R.; Hoffmeyer, M.R.; Farvid, A.R.; Gibson, M.F.; Lefer, A.M. 2001: HMG-CoA reductase inhibition protects the diabetic myocardium from ischemia-reperfusion injury. FASEB Journal 15(8): 1454-1456
Usui, H.; Shikata, K.; Matsuda, M.; Okada, S.; Ogawa, D.; Yamashita, T.; Hida, K.; Satoh, M.; Wada, J.; Makino, H. 2003: HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 18(2): 265-272
Horimoto, H.; Nakai, Y.; Nakahara, K.ich.; Nomura, Y.; Mieno, S.; Sasaki, S. 2002: HMG-CoA reductase inhibitor cerivastatin prolonged rat cardiac allograft survival by blocking intercellular signals. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 21(4): 440-445
Sone, H.; Takahashi, A.; Shimano, H.; Ishibashi, S.; Yoshino, G.; Morisaki, N.; Saito, Y.; Kawazu, S.; Teramoto, T.; Fujita, T.; Shiba, T.; Iwamoto, Y.; Kuzuya, N.; Akanuma, Y.; Yamada, N. 2002: HMG-CoA reductase inhibitor decreases small dense low-density lipoprotein and remnant-like particle cholesterol in patients with type-2 diabetes. Life Sciences 71(20): 2403-2412
Yamamoto, T.; Takeda, K.; Harada, S.; Nakata, T.; Azuma, A.; Sasaki, S.; Nakagawa, M. 2003: HMG-CoA reductase inhibitor enhances inducible nitric oxide synthase expression in rat vascular smooth muscle cells; involvement of the Rho/Rho kinase pathway. Atherosclerosis 166(2): 213-222
Kawashima, S.; Yamashita, T.; Miwa, Y.; Ozaki, M.; Namiki, M.; Hirase, T.; Inoue, N.; Hirata, K-ichi.; Yokoyama, M. 2003: HMG-CoA reductase inhibitor has protective effects against stroke events in stroke-prone spontaneously hypertensive rats. Stroke 34(1): 157-163
Hattori, Y.; Nakanishi, N.; Akimoto, K.; Yoshida, M.; Kasai, K. 2003: HMG-CoA reductase inhibitor increases GTP cyclohydrolase I mRNA and tetrahydrobiopterin in vascular endothelial cells. Arteriosclerosis Thrombosis and Vascular Biology 23(2): 176-182
Kumano, T.; Mutoh, T.; Nakagawa, H.; Kuriyama, M. 2000: HMG-CoA reductase inhibitor induces a transient activation of high affinity nerve growth factor receptor, Trk, and morphological differentiation with fatal outcome in PC12 cells. Brain Research 859(1): 169-172
Wächtershäuser, A.; Akoglu, B.; Stein, J. 2001: HMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2. Carcinogenesis 22(7): 1061-1067
Llevadot, J.; Murasawa, S.; Kureishi, Y.; Uchida, S.; Masuda, H.; Kawamoto, A.; Walsh, K.; Isner, J.M.; Asahara, T. 2001: HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells. Journal of Clinical Investigation 108(3): 399-405
Yoshida, M.; Sawada, T.; Ishii, H.; Gerszten, R.E.; Rosenzweig, A.; Gimbrone, M.A.; Yasukochi, Y.; Numano, F. 2001: HMG-CoA reductase inhibitor modulates monocyte-endothelial cell interaction under physiological flow conditions in vitro: Involvement of Rho GTPase-dependent mechanism. Arteriosclerosis Thrombosis and Vascular Biology 21(7): 1165-1171
Nakagawa, H.; Mutoh, T.; Kumano, T.; Kuriyama, M. 1998: HMG-CoA reductase inhibitor-induced L6 myoblast cell death: Involvement of the phosphatidylinositol 3-kinase pathway. FEBS Letters 438(3): 289-292
Wang, E.; Casciano, C.N.; Clement, R.P.; Johnson, W.W. 2001: HMG-CoA reductase inhibitors (statins) characterized as direct inhibitors of P-glycoprotein. Pharmaceutical Research 18(6): 800-806
Hess, D.C.; Demchuk, A.M.; Brass, L.M.; Yatsu, F.M. 2000: HMG-CoA reductase inhibitors (statins): a promising approach to stroke prevention. Neurology 54(4): 790-796
Meier, C.R.; Schlienger, R.G.; Kraenzlin, M.E.; Schlegel, B.; Jick, H. 2000: HMG-CoA reductase inhibitors and the risk of fractures. JAMA 283(24): 3205-3210
Wang, P.S.; Solomon, D.H.; Mogun, H.; Avorn, J. 2000: HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA 283(24): 3211-3216
Wassmann, S.; Laufs, U.; Bäumer, A.T.; Müller, K.; Ahlbory, K.; Linz, W.; Itter, G.; Rösen, R.; Böhm, M.; Nickenig, G. 2001: HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension 37(6): 1450-1457
Riahi, S.; Christensen, J.Hagstrup.; Toft, E.; Skou, H.Aarup.; Schmidt, E.Berg. 2002: HMG-CoA reductase inhibitors improve heart rate variability in patients with a previous myocardial infarction. Pharmacological Research 45(6): 479-483
Chung, Y.S.; Lee, M.D.; Lee, S.K.; Kim, H.M.; Fitzpatrick, L.A. 2000: HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients. Journal of clinical endocrinology and metabolism 85(3): 1137-1142
Erl, W.; Hristov, M.; Neureuter, M.; Yan, Z-Qun.; Hansson, Göran.K.; Weber, P.C. 2003: HMG-CoA reductase inhibitors induce apoptosis in neointima-derived vascular smooth muscle cells. Atherosclerosis 169(2): 251-258
Huang, K-Chin.; Chen, C-Wen.; Chen, J-Ching.; Lin, W-Wan. 2003: HMG-CoA reductase inhibitors inhibit inducible nitric oxide synthase gene expression in macrophages. Journal of Biomedical Science 10(4): 396-405
Yasunari, K.; Maeda, K.; Minami, M.; Yoshikawa, J. 2001: HMG-CoA reductase inhibitors prevent migration of human coronary smooth muscle cells through suppression of increase in oxidative stress. Arteriosclerosis Thrombosis and Vascular Biology 21(6): 937-942
Bellosta, S.; Via, D.; Canavesi, M.; Pfister, P.; Fumagalli, R.; Paoletti, R.; Bernini, F. 1998: HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages. Arteriosclerosis Thrombosis and Vascular Biology 18(11): 1671-1678
Teupser, D.; Bruegel, M.; Stein, O.; Stein, Y.; Thiery, J. 2001: HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells. Biochemical and Biophysical Research Communications 289(4): 838-844
Ito, T.; Ikeda, U.; Shimpo, M.; Ohki, R.; Takahashi, M.; Yamamoto, K.; Shimada, K. 2002: HMG-CoA reductase inhibitors reduce interleukin-6 synthesis in human vascular smooth muscle cells. Cardiovascular Drugs and Therapy 16(2): 121-126
Assmus, B.; Urbich, C.; Aicher, A.; Hofmann, W.K.; Haendeler, J.; Rössig, L.; Spyridopoulos, I.; Zeiher, A.M.; Dimmeler, S. 2003: HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circulation Research 92(9): 1049-1055
Martínez-González, J.; Alfón, J.; Berrozpe, M.; Badimon, L. 2001: HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels. Atherosclerosis 159(1): 27-33
Dichtl, W.; Dulak, J.; Frick, M.; Alber, H.F.; Schwarzacher, S.P.; Ares, M.P.S.; Nilsson, J.; Pachinger, O.; Weidinger, F. 2003: HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells. Arteriosclerosis Thrombosis and Vascular Biology 23(1): 58-63
Kawagoe, Y.; Kato, T.; Kase, H.; Suzuki, M.; Sato, N. 2003: HMG-CoA reductase inhibitors suppress high glucose-induced excessive O2- production in J-774 cells. Dokkyo Journal of Medical Sciences 30(1): 13-21
Yokoyama, K.; Ishibashi, T.; Ohkawara, H.; Kimura, J.; Matsuoka, I.; Sakamoto, T.; Nagata, K.; Sugimoto, K.; Sakurada, S.; Maruyama, Y. 2002: HMG-CoA reductase inhibitors suppress intracellular calcium mobilization and membrane current induced by lysophosphatidylcholine in endothelial cells. Circulation 105(8): 962-967
Puddu, P.; Puddu, G.M.; Muscari, A. 2001: HMG-CoA reductase inhibitors: Is the endothelium the main target?. Cardiology 95(1): 9-13
Liang, K.; Vaziri, N.D. 2003: HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LCAT, ACAT, LDL receptor, and SRB-1 in hereditary analbuminemia. Kidney International 64(1): 192-198
Ner, S.S.; Blank, T.; Pérez-Paralle, M.L.; Grigliatti, T.A.; Becker, P.B.; Travers, A.A. 2001: HMG-D and histone H1 interplay during chromatin assembly and early embryogenesis. Journal of Biological Chemistry 276(40): 37569-37576
Cerdan, R.; Payet, D.; Yang, J.C.; Travers, A.A.; Neuhaus, D. 2001: HMG-D complexed to a bulge DNA: an NMR model. Protein Science: a Publication of the Protein Society 10(3): 504-518
Bouallaga, I.; Teissier, Sébastien.; Yaniv, M.; Thierry, Fçoise. 2003: HMG-I(Y) and the CBP/p300 coactivator are essential for human papillomavirus type 18 enhanceosome transcriptional activity. Molecular and Cellular Biology 23(7): 2329-2340
Liu, W.M.; Guerra-Vladusic, F.K.; Kurakata, S.; Lupu, R.; Kohwi-Shigematsu, T. 1999: HMG-I(Y) recognizes base-unpairing regions of matrix attachment sequences and its increased expression is directly linked to metastatic breast cancer phenotype. Cancer Research 59(22): 5695-5703
Wood, L.J.; Mukherjee, M.; Dolde, C.E.; Xu, Y.; Maher, J.F.; Bunton, T.E.; Williams, J.B.; Resar, L.M. 2000: HMG-I/Y, a new c-Myc target gene and potential oncogene. Molecular and Cellular Biology 20(15): 5490-5502
Cohen, S.M.; Mikata, Y.; He, Q.; Lippard, S.J. 2000: HMG-domain protein recognition of cisplatin 1,2-intrastrand d(GpG) cross-links in purine-rich sequence contexts. Biochemistry 39(38): 11771-11776
Thomas, J.O.; Travers, A.A. 2001: HMG1 and 2, and related 'architectural' DNA-binding proteins. Trends in Biochemical Sciences 26(3): 167-174
Stros, M.; Cherny, D.; Jovin, T.M. 2000: HMG1 protein stimulates DNA end joining by promoting association of DNA molecules via their ends. European Journal of Biochemistry 267(13): 4088-4097
Wiśniewski, J.R.; Krohn, N.M.; Heyduk, E.; Grasser, K.D.; Heyduk, T. 1999: HMG1 proteins from evolutionary distant organisms distort B-DNA conformation in similar way. Biochimica et Biophysica Acta 1447(1): 25-34
Fan, Z.; Beresford, P.J.; Zhang, D.; Lieberman, J. 2002: HMG2 interacts with the nucleosome assembly protein SET and is a target of the cytotoxic T-lymphocyte protease granzyme A. Molecular and Cellular Biology 22(8): 2810-2820
Sumoy, L.; Carim, L.; Escarceller, M.; Nadal, M.; Gratacòs, M.; Pujana, M.A.; Estivill, X.; Peral, B. 2000: HMG20A and HMG20B map to human chromosomes 15q24 and 19p13.3 and constitute a distinct class of HMG-box genes with ubiquitous expression. Cytogenetics and Cell Genetics 88(1-2): 62-67
Masciullo, V.; Baldassarre, G.; Pentimalli, F.; Berlingieri, M.T.; Boccia, A.; Chiappetta, G.; Palazzo, J.; Manfioletti, G.; Giancotti, V.; Viglietto, G.; Scambia, G.; Fusco, A. 2003: HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas. Carcinogenesis 24(7): 1191-1198
Gross, K.L.; Neskey, D.M.; Manchanda, N.; Weremowicz, S.; Kleinman, M.S.; Nowak, R.A.; Ligon, A.H.; Rogalla, P.; Drechsler, K.; Bullerdiek, J.ör.; Morton, C.C. 2003: HMGA2 expression in uterine leiomyomata and myometrium: quantitative analysis and tissue culture studies. Genes Chromosomes and Cancer 38(1): 68-79
Ashar, H.R.; Tkachenko, A.; Shah, P.; Chada, K. 2003: HMGA2 is expressed in an allele-specific manner in human lipomas. Cancer Genetics and Cytogenetics 143(2): 160-168
Pierantoni, G.Maria.; Santulli, B.; Caliendo, I.; Pentimalli, F.; Chiappetta, G.; Zanesi, N.; Santoro, M.; Bulrich, F.; Fusco, A. 2003: HMGA2 locus rearrangement in a case of acute lymphoblastic leukemia. International Journal of Oncology 23(2): 363-367
Agnello, D.; Wang, H.; Yang, H.; Tracey, K.J.; Ghezzi, P. 2002: HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion. Cytokine 18(4): 231-236
Sappington, P.L.; Yang, R.; Yang, H.; Tracey, K.J.; Delude, R.L.; Fink, M.P. 2002: HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology 123(3): 790-802
Stros, M.; Ozaki, T.; Bacikova, A.; Kageyama, H.; Nakagawara, A. 2002: HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter. Journal of Biological Chemistry 277(9): 7157-7164
Andersson, U.; Erlandsson-Harris, H.; Yang, H.; Tracey, K.J. 2002: HMGB1 as a DNA-binding cytokine. Journal of Leukocyte Biology 72(6): 1084-1091
Wang, H.; Yang, H.; Czura, C.J.; Sama, A.E.; Tracey, K.J. 2001: HMGB1 as a late mediator of lethal systemic inflammation. American Journal of Respiratory and Critical Care Medicine 164(10 Part 1): 1768-1773
Andersson, U.; Tracey, K.J. 2003: HMGB1 in sepsis. Scandinavian Journal of Infectious Diseases 35(9): 577-584
Brezniceanu, M-Luise.; Völp, K.; Bösser, S.; Solbach, C.; Lichter, P.; Joos, S.; Zörnig, M. 2003: HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma. FASEB Journal 17(10): 1295-1297
Agresti, A.; Lupo, R.; Bianchi, M.E.; Müller, S. 2003: HMGB1 interacts differentially with members of the Rel family of transcription factors. Biochemical and Biophysical Research Communications 302(2): 421-426
Dintilhac, A.ès.; Bernués, J. 2002: HMGB1 interacts with many apparently unrelated proteins by recognizing short amino acid sequences. Journal of Biological Chemistry 277(9): 7021-7028
Guazzi, S.; Strangio, A.; Franzi, A.T.; Bianchi, M.E. 2003: HMGB1, an architectural chromatin protein and extracellular signalling factor, has a spatially and temporally restricted expression pattern in mouse brain. Gene Expression Patterns: Gep 3(1): 29-33
Kazmierczak, B.; Dal Cin, P.; Meyer-Bolte, K.; Van den Berghe, H.; Bullerdiek, J. 1999: HMG1 is not rearranged by 13q12 aberrations in lipomas. Genes Chromosomes and Cancer 24(3): 290-292
Giannini, G.; Di Marcotullio, L.; Ristori, E.; Zani, M.; Crescenzi, M.; Scarpa, S.; Piaggio, G.; Vacca, A.; Peverali, F.A.; Diana, F.; Screpanti, I.; Frati, L.; Gulino, A. 1999: HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness. Cancer Research 59(10): 2484-2492
Scala, S.; Portella, G.; Vitagliano, D.; Ledent, C.; Chiappetta, G.; Giancotti, V.; Dumont, J.; Fusco, A. 2001: HMGI-C gene expression is not required for in vivo thyroid cell transformation. Carcinogenesis 22(2): 251-256
Reeves, R.; Beckerbauer, L. 2001: HMGI/Y proteins: Flexible regulators of transcription and chromatin structure. Biochimica et Biophysica Acta 1519(1-2): 13-29
Hisaoka, M.; Sheng, W.Qi.; Tanaka, A.; Hashimoto, H. 2002: HMGIC alterations in smooth muscle tumors of soft tissues and other sites. Cancer Genetics and Cytogenetics 138(1): 50-55
Gattas, G.J.; Quade, B.J.; Nowak, R.A.; Morton, C.C. 1999: HMGIC expression in human adult and fetal tissues and in uterine leiomyomata. Genes Chromosomes and Cancer 25(4): 316-322
Rogalla, P.; Drechsler, K.; Schröder-Babo, W.; Eberhardt, K.; Bullerdiek, J. 1998: HMGIC expression patterns in non-small lung cancer and surrounding tissue. Anticancer Research 18(5a): 3327-3330
West, K.L.; Ito, Y.; Birger, Y.; Postnikov, Y.; Shirakawa, H.; Bustin, M. 2001: HMGN3a and HMGN3b, two protein isoforms with a tissue-specific expression pattern, expand the cellular repertoire of nucleosome-binding proteins. Journal of Biological Chemistry 276(28): 25959-25969
Birger, Y.; Ito, Y.; West, K.L.; Landsman, D.; Bustin, M. 2001: HMGN4, a newly discovered nucleosome-binding protein encoded by an intronless gene. Dna and Cell Biology 20(5): 257-264
Huang-Jing; Shi-Feng [author, Reprint-Author]; Zou-Xiu-Fen; Li-Yuan-Xiang; Zhou-Huai-Bei 2003: HMM in predicting protein secondary structure. Wuhan University Journal of Natural Sciences 8(1B): 307-310
Nishio, M.; Watanabe, Y.; Hidaka, H. 1998: HMN-1180, a small molecule inhibitor of neuronal nitric oxide synthase. Journal of Pharmacology and Experimental Therapeutics 287(3): 1063-1067
Tanaka, H.; Ohshima, N.; Ikenoya, M.; Komori, K.; Katoh, F.; Hidaka, H. 2003: HMN-176, an active metabolite of the synthetic antitumor agent HMN-214, restores chemosensitivity to multidrug-resistant cells by targeting the transcription factor NF-Y. Cancer Research 63(20): 6942-6947
Staff, R.T.; Venneri, A.; Gemmell, H.G.; Shanks, M.F.; Pestell, S.J.; Murray, A.D. 2000: HMPAO SPECT imaging of Alzheimer's disease patients with similar content-specific autobiographic delusion: comparison using statistical parametric mapping. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 41(9): 1451-1455
Wirth, K.J.; Klaus, E.; Englert, H.G.; Schölkens, B.A.; Linz, W. 1999: HMR 1883, a cardioselective K(ATP) channel blocker, inhibits ischaemia- and reperfusion-induced ventricular fibrillation in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 360(3): 295-300
Piroth, L.; Desbiolles, N.; Mateo-Ponce, V.; Martin, L.; Lequeu, C.; Charles, P.E.; Portier, H.; Chavanet, P. 2001: HMR 3647 human-like treatment of experimental pneumonia due to penicillin-resistant and erythromycin-resistant Streptococcus pneumoniae. Journal of Antimicrobial ChemoTherapy 47(1): 33-42
Kissel, K.; Hofmann, C.; Gittinger, F.S.; Daniels, G.; Bux, J. 2000: HNA-1a, HNA-1b, and HNA-1c (NA1, NA2, SH) frequencies in African and American Blacks and in Chinese. Tissue Antigens 56(2): 143-148
Parola, M.; Robino, G.; Marra, F.; Pinzani, M.; Bellomo, G.; Leonarduzzi, G.; Chiarugi, P.; Camandola, S.; Poli, G.; Waeg, G.; Gentilini, P.; Dianzani, M.U. 1998: HNE interacts directly with JNK isoforms in human hepatic stellate cells. Journal of Clinical Investigation 102(11): 1942-1950
Salomon, R.G.; Kaur, K.; Podrez, E.; Hoff, H.F.; Krushinsky, A.V.; Sayre, L.M. 2000: HNE-derived 2-pentylpyrroles are generated during oxidation of LDL, are more prevalent in blood plasma from patients with renal disease or atherosclerosis, and are present in atherosclerotic plaques. Chemical Research in Toxicology 13(7): 557-564
Ono, M.; Hosoe, Y.; Azuma, S.; Shoji, M.; Nara, K.; Kondo, N.; Shiba, T.; Takamatsu, N. 2001: HNF-1 regulates the liver-specific transcription of the chipmunk HP-20 gene. Gene 277(1-2): 121-127
Triggs-Raine, B.L.; Kirkpatrick, R.D.; Kelly, S.L.; Norquay, L.D.; Cattini, P.A.; Yamagata, K.; Hanley, A.J.G.; Zinman, B.; Harris, S.B.; Barrett, P.H.; Hegele, R.A. 2002: HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community. Proceedings of the National Academy of Sciences of the United States of America 99(7): 4614-4619
Divine, J.K.; McCaul, S.P.; Simon, T.C. 2003: HNF-1alpha and endodermal transcription factors cooperatively activate Fabpl: MODY3 mutations abrogate cooperativity. American Journal of Physiology. Gastrointestinal and Liver Physiology 285(1): G62-G72
Tichelaar, J.W.; Wert, S.E.; Costa, R.H.; Kimura, S.; Whitsett, J.A. 1999: HNF-3/forkhead homologue-4 (HFH-4) is expressed in ciliated epithelial cells in the developing mouse lung. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 47(6): 823-832
McGee-Estrada, K.; Palmarini, M.; Fan, H. 2002: HNF-3beta is a critical factor for the expression of the Jaagsiekte sheep retrovirus long terminal repeat in type Ii pneumocytes but not in Clara cells. Virology 292(1): 87-97
Kojima, M.; Takamatsu, N.; Ishii, T.; Kondo, N.; Shiba, T. 2000: HNF-4 plays a pivotal role in the liver-specific transcription of the chipmunk HP-25 gene. European Journal of Biochemistry 267(15): 4635-4641
Houard, N.; Rousseau, G.G.; Lemaigre, F.P. 2003: HNF-6-independent differentiation of mouse embryonic stem cells into insulin-producing cells. Diabetologia 46(3): 378-385
Pontoglio, M.; Prié, D.; Cheret, C.; Doyen, A.; Leroy, C.; Froguel, P.; Velho, G.; Yaniv, M.; Friedlander, G. 2000: HNF1alpha controls renal glucose reabsorption in mouse and man. Embo Reports 1(4): 359-365
Vignali, R.; Poggi, L.; Madeddu, F.; Barsacchi, G. 2000: HNF1(beta) is required for mesoderm induction in the Xenopus embryo. Development 127(7): 1455-1465
Denson, L.A.; McClure, M.H.; Bogue, C.W.; Karpen, S.J.; Jacobs, H.C. 2000: HNF3beta and GATA-4 transactivate the liver-enriched homeobox gene, Hex. Gene 246(1-2): 311-320
Perea-Gómez, A.; Shawlot, W.; Sasaki, H.; Behringer, R.R.; Ang, S. 1999: HNF3beta and Lim1 interact in the visceral endoderm to regulate primitive streak formation and anterior-posterior polarity in the mouse embryo. Development 126(20): 4499-4511
Stroup, D.; Chiang, J.Y. 2000: HNF4 and COUP-TFII interact to modulate transcription of the cholesterol 7alpha-hydroxylase gene (CYP7A1). Journal of Lipid Research 41(1): 1-11
Chou, D.K.H.; Schachner, M.; Jungalwala, F.B. 2002: HNK-1 sulfotransferase null mice express glucuronyl glycoconjugates and show normal cerebellar granule neuron migration in vivo and in vitro. Journal of Neurochemistry 82(5): 1239-1251
Shibata, S.; Takagaki, K.; Ishido, K.; Konn, M.; Sasaki, M.; Endo, M. 2003: HNK-1-Reactive oligosaccharide, sulfate-O-3GlcAbeta1-4Xylbeta1-MU, synthesized by cultured human colorectal cancer cells. Tohoku Journal of Experimental Medicine 199(1): 13-23
Yamamoto, M.; Tamaki, M.; Bandow, H.; Maeda, Y. 2001: HNO3 analyzer by scrubber difference and the NO-ozone chemiluminescence method. Atmospheric Environment 35(31): 5339-5346
Li-Jones, X.; Savoie, D., L.; Prospero, J., M. 2001: HNO3 losses within the cyclone inlet of a diffusion-denuder system under simulated marine environments. Atmospheric Environment 35(5): 985-993
Kumar, V.; Yang, T. 2002: HNO3/H3PO4-NaNO2 mediated oxidation of cellulose: Preparation and characterization of bioabsorbable oxidized celluloses in high yields and with different levels of oxidation. Carbohydrate Polymers 48(4): 403-412, 1 June
Heinen, C.D.; Wilson, T.; Mazurek, A.; Berardini, M.; Butz, C.; Fishel, R. 2002: HNPCC mutations in hMSH2 result in reduced hMSH2-hMSH6 molecular switch functions. Cancer Cell 1(5): 469-478
Nodera, H.; Nishimura, M.; Logigian, E.L.; Herrmann, D.N.; Kaji, R. 2003: HNPP due to a novel missense mutation of the PMP22 gene. Neurology 60(11): 1863-1864
Tanaka, Y.; Mitani, A.; Igarashi, T.; Someya, S.; Otsuka, K.; Imai, T.; Yamaki, F.; Tanaka, H.; Saitoh, M.; Nakazawa, T.; Noguchi, K.; Hashimoto, K.; Shigenobu, K. 2001: HNS-32, a novel azulene-1-carboxamidine derivative, inhibits nifedipine-sensitive and -insensitive contraction of the isolated rabbit aorta. Naunyn-Schmiedeberg's Archives of Pharmacology 363(3): 344-352
Malkova, A.; Klein, F.; Leung, W.Y.; Haber, J.E. 2000: HO endonuclease-induced recombination in yeast meiosis resembles Spo11-induced events. Proceedings of the National Academy of Sciences of the United States of America 97(26): 14500-14505
Barrera, D.; Maldonado, P.D.; Medina-Campos, O.N.; Hernández-Pando, R.; Ibarra-Rubio, Mía.E.; Pedraza-Chaverrí, Jé.; Pedraza-Chaverrrí, Jé. 2003: HO-1 induction attenuates renal damage and oxidative stress induced by K2Cr2O7. Free Radical Biology and Medicine 34(11): 1390-1398
Perrière, G.; Duret, L.; Gouy, M. 2000: HOBACGEN: database system for comparative genomics in bacteria. Genome Research 10(3): 379-385
Vitt, L.J.; Sartorius, S.S. 1999: HOBOs, Tidbits and lizard models: The utility of electronic devices in field studies of ectotherm thermoregulation. Functional Ecology 13(5): 670-674
Li, P.; Xu, J.C.eng 2000: HOBt and HOAt-derived immonium salts: New and highly efficient coupling reagents for peptide synthesis. Tetrahedron Letters 41(5): 721-724
Draijer, R.; Volger, O.L.; Dahlmans, V.E.H.; de Wit, E.C.M.; Havekes, L.M.; Princen, H.M.G. 2002: HOE 402 lowers serum cholesterol levels by reducing VLDL-lipid production, and not by induction of the LDL receptor, and reduces atherosclerosis in wild-type and LDL receptor-deficient mice. Biochemical Pharmacology 63(9): 1755-1761
Mizuguchi, K.; Deane, C.M.; Blundell, T.L.; Overington, J.P. 1998: HOMSTRAD: a database of protein structure alignments for homologous families. Protein Science: a Publication of the Protein Society 7(11): 2469-2471
De Bakker, P.I.; Bateman, A.; Burke, D.F.; Miguel, R.N.; Mizuguchi, K.; Shi, J.; Shirai, H.; Blundell, T.L. 2001: HOMSTRAD: adding sequence information to structure-based alignments of homologous protein families. Bioinformatics 17(8): 748-749
Umland, O.; Ulmer, A.J.; Vollmer, E.; Goldmann, T. 2003: HOPE fixation of cytospin preparations of human cells for in situ hybridization and immunocytochemistry. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 51(7): 977-980
Olert, J.; Wiedorn, K.H.; Goldmann, T.; Kühl, H.; Mehraein, Y.; Scherthan, H.; Niketeghad, F.; Vollmer, E.; Müller, A.M.; Müller-Navia, J. 2001: HOPE fixation: a novel fixing method and paraffin-embedding technique for human soft tissues. Pathology Research and Practice 197(12): 823-826
Hemels, M.E.H.; Bennett, H.A.; Bonari, L.; Han, D.; Traverso, M.L.; Einarson, T.R. 2003: HOPE study impact on ACE inhibitors use. Annals of PharmacoTherapy 37(5): 640-645
Holland, A.J.; Smith, G.H.; Ross, F.I.; Cass, D.T. 2001: HOSE: An objective scoring system for evaluating the results of hypospadias surgery. BJU International 88(3): 255-258
Robinson, G.S. 1999: HOSTS: A database of the host plants of the world's Lepidoptera. Nota Lepidopterologica 22(1): 35-47
Haas, R.L.M.; Girinsky, T. 2003: HOVON 47/EORTC 20013: chlorambucil vs 2x2 Gy involved field radiotherapy in stage III/IV previously untreated follicular lymphoma patients. Annals of Hematology 82(7): 458-462
Owens, B.M.; Hawley, R.G. 2002: HOX and non-HOX homeobox genes in leukemic hematopoiesis. Stem Cells 20(5): 364-379
Taylor, H.S.; Bagot, C.; Kardana, A.; Olive, D.; Arici, A. 1999: HOX gene expression is altered in the endometrium of women with endometriosis. Human Reproduction 14(5): 1328-1331
Cantile, M.; Procino, A.; D'Armiento, M.; Cindolo, L.; Cillo, C. 2003: HOX gene network is involved in the transcriptional regulation of in vivo human adipogenesis. Journal of Cellular Physiology 194(2): 225-236
Zaraisky, A.G. 2001: HOX genes in embryogenesis and phylogenesis. Ontogenez- 32(1): 3-13
Golpon, H.A.; Geraci, M.W.; Moore, M.D.; Miller, H.L.; Miller, G.J.; Tuder, R.M.; Voelkel, N.F. 2001: HOX genes in human lung: altered expression in primary pulmonary hypertension and emphysema. American Journal of Pathology 158(3): 955-966
Taghon, T.; Stolz, F.; De Smedt, M.; Cnockaert, M.; Verhasselt, B.; Plum, J.; Leclercq, G. 2002: HOX-A10 regulates hematopoietic lineage commitment: evidence for a monocyte-specific transcription factor. Blood 99(4): 1197-1204
Puliti, A.; Cinti, R.; Betsos, N.; Romeo, G.; Ceccherini, I. 1999: HOX11L1, a gene involved in peripheral nervous system development, maps to human chromosome 2p13.1 fwdarw p12 and mouse chromosome 6C3-D1. Cytogenetics and Cell Genetics 84(1-2): 115-117
Fava, M.; Borghini, S.; Cinti, R.; Cusano, R.; Seri, M.; Lerone, M.; De Giorgio, R.; Stanghellini, V.; Martucciello, G.; Ravazzolo, R.; Ceccherini, I. 2002: HOX11L1: a promoter study to evaluate possible expression defects in intestinal motility disorders. International Journal of Molecular Medicine 10(1): 101-106
Ballerini, P.; Blaise, A.; Busson-Le Coniat, M.; Su, X.Y.; Zucman-Rossi, J.; Adam, M.; van den Akker, J.; Perot, C.; Pellegrino, B.; Landman-Parker, J.; Douay, L.; Berger, R.; Bernard, O.A. 2002: HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis. Blood 100(3): 991-997
Cermik, D.; Karaca, M.; Taylor, H.S. 2001: HOXA10 expression is repressed by progesterone in the myometrium: differential tissue-specific regulation of HOX gene expression in the reproductive tract. Journal of Clinical Endocrinology and Metabolism 86(7): 3387-3392
Chau, Y.M.; Pando, S.; Taylor, H.S. 2002: HOXA11 silencing and endogenous HOXA11 antisense ribonucleic acid in the uterine endometrium. Journal of Clinical Endocrinology and Metabolism 87(6): 2674-2680
Shen, W.F.; Rozenfeld, S.; Kwong, A.; Köm ves, L.G.; Lawrence, H.J.; Largman, C. 1999: HOXA9 forms triple complexes with PBX2 and MEIS1 in myeloid cells. Molecular and Cellular Biology 19(4): 3051-3061
Kömüves, L.ás.ó G.; Ma, X.-K.; Stelnicki, E.; Rozenfeld, S.; Oda, Y.; Largman, C. 2003: HOXB13 homeodomain protein is cytoplasmic throughout fetal skin development. Developmental Dynamics: An Official Publication of the American Association of Anatomists 227(2): 192-202
Kömüves, L.ás.ó G.; Michael, E.; Arbeit, J.M.; Ma, X.-K.; Kwong, A.; Stelnicki, E.; Rozenfeld, S.; Morimune, M.; Yu, Q.-C.; Largman, C. 2002: HOXB4 homeodomain protein is expressed in developing epidermis and skin disorders and modulates keratinocyte proliferation. Developmental Dynamics: An Official Publication of the American Association of Anatomists 224(1): 58-68
Antonchuk, J.; Sauvageau, G.; Humphries, R.K. 2001: HOXB4 overexpression mediates very rapid stem cell regeneration and competitive hematopoietic repopulation. Experimental Hematology 29(9): 1125-1134
Fu, M.; Lui, V.C.H.; Sham, M.H.; Cheung, A.N.Y.; Tam, P.K.H. 2003: HOXB5 expression is spatially and temporarily regulated in human embryonic gut during neural crest cell colonization and differentiation of enteric neuroblasts. Developmental Dynamics: An Official Publication of the American Association of Anatomists 228(1): 1-10
Meccia, E.; Bottero, L.; Felicetti, F.; Peschle, C.; Colombo, M.P.; Carè, A. 2003: HOXB7 expression is regulated by the transcription factors NF-Y, YY1, Sp1 and USF-1. Biochimica et Biophysica Acta 1626(1-3): 1-9
Boström, K.; Tintut, Y.; Kao, S.C.; Stanford, W.P.; Demer, L.L. 2000: HOXB7 overexpression promotes differentiation of C3H10T1/2 cells to smooth muscle cells. Journal of Cellular Biochemistry 78(2): 210-221
Jave-Suarez, L.F.; Winter, H.; Langbein, L.; Rogers, M.A.; Schweizer, J.ür. 2002: HOXC13 is involved in the regulation of human hair keratin gene expression. Journal of Biological Chemistry 277(5): 3718-3726
Alami, Y.; Castronovo, V.; Belotti, D.; Flagiello, D.; Clausse, N. 1999: HOXC5 and HOXC8 expression are selectively turned on in human cervical cancer cells compared to normal keratinocytes. Biochemical and Biophysical Research Communications 257(3): 738-745
Kjaer, K.W.; Hedeboe, J.; Bugge, M.; Hansen, C.; Friis-Henriksen, K.; Vestergaard, M.B.; Tommerup, N.; Opitz, J.M. 2002: HOXD13 polyalanine tract expansion in classical synpolydactyly type Vordingborg. American Journal of Medical Genetics 110(2): 116-121
Taniguchi, Y.; Moriuchi, T.; Inoko, H.; Kimura, M. 2003: HOXD3 mediates the switchover of cadherin 4 to beta3 integrin gene expression in human erythroleukemia HEL cells. Biomedical Research 24(3): 133-140
Meehan, R.R.; Kao, C-Fu.; Pennings, S. 2003: HP1 binding to native chromatin in vitro is determined by the hinge region and not by the chromodomain. EMBO Journal 22(12): 3164-3174
Shareef, M.M.; Badugu, R.; Kellum, R. 2003: HP1/ORC complex and heterochromatin assembly. Genetica 117(2-3): 127-134
Singh, P.B.; Georgatos, S.D. 2002: HP1: Facts, open questions, and speculation. Journal of Structural Biology 140(1-3): 10-16
Metzler-Guillemain, C.; Luciani, J.; Depetris, D.; Guichaoua, M.R.; Mattei, M.G. 2003: HP1beta and HP1gamma, but not HP1alpha, decorate the entire XY body during human male meiosis. Chromosome Research: An International Journal on the Molecular Supramolecular and Evolutionary Aspects of Chromosome Biology 11(1): 73-81
Minc, E.; Courvalin, J.C.; Buendia, B. 2000: HP1gamma associates with euchromatin and heterochromatin in mammalian nuclei and chromosomes. Cytogenetics and Cell Genetics 90(3-4): 279-284
Nakadai, T.; Kishimoto, T.; Miyazawa, Y.; Okada, N.; Makino, Y.; Obinata, T.; Tamura, T. 1999: HP33: hepatocellular carcinoma-enriched 33-kDa protein with similarity to mitochondrial N-acyltransferase but localized in a microtubule-dependent manner at the centrosome. Journal of Cell Science 112: 1353-1364
Majewska, Maria Dorota 2002: HPA axis and stimulant dependence: An enigmatic relationship. Psychoneuroendocrinology 27(1-2): 5-12
Pitchot, W.; Herrera, C.; Ansseau, M. 2001: HPA axis dysfunction in major depression: relationship to 5-HT(1A) receptor activity. Neuropsychobiology 44(2): 74-77
Groenink, L.; Dirks, A.; Verdouw, P.Monika.; Schipholt, M.lutje.; Veening, J.G.; van der Gugten, J.; Olivier, B. 2002: HPA axis dysregulation in mice overexpressing corticotropin releasing hormone. Biological Psychiatry 51(11): 875-881
Kosten, T.A.; Ambrosio, E. 2002: HPA axis function and drug addictive behaviors: Insights from studies with Lewis and Fischer 344 inbred rats. Psychoneuroendocrinology 27(1-2): 35-69
Condren, R.M.; O'neill, A.; Ryan, M.C.M.; Barrett, P.; Thakore, J.H. 2002: HPA axis response to a psychological stressor in generalised social phobia. Psychoneuroendocrinology 27(6): 693-703
Metcalfe, P.; Cavanagh, G.; Hurd, C.; Ouwehand, W.H. 1999: HPA genotyping by PCR-SSP: report of 4 exercises. Vox Sanguinis 77(1): 40-43
Stokes, P.E.; Sikes, C.; Lasley, B.; Stoll, P. 2002: HPA hyperactivity with increased plasma cortisol affects dexamethasone metabolism and DST outcome. Journal of Psychiatric Research 36(6): 417-421
Böttiger, C.; Kastrati, A.; Koch, W.; Mehilli, J.; Seidl, H.; Schömig, K.; von Beckerath, N.; Schömig, A. 2000: HPA-1 and HPA-3 polymorphisms of the platelet fibrinogen receptor and coronary artery disease and myocardial infarction. Thrombosis and Haemostasis 83(4): 559-562
Göpel, W.; Fehlau, K.; Kohl, M.; Schultz, C.; Möller, J. 2002: HPA-1 carrier status and thrombocytopenia in preterm infants with a birth weight below 1500 grams. Journal of Perinatal Medicine 30(2): 176-178
Verran, J.; Grey, D.; Bennett, J.; Lown, J.A.; Erber, W.N. 2000: HPA-1, 3, 5 genotyping to establish a typed platelet donor panel. Pathology 32(2): 89-93
Versari, A.; Biesenbruch, S.; Barbanti, D.; Farnell, P.J.; Galassi, S. 1999: HPAEC-PAD analysis of oligogalacturonic acids in strawberry juice. Food Chemistry 66(2): 257-261
Mascotti, K.; Mccullough, J.; Burger, S.R. 2000: HPC viability measurement: Trypan blue versus acridine orange and propidium iodide. Transfusion 40(6): 693-696
Watanabe, T.; Fujiwara, T.; Komazaki, S.; Yamaguchi, K.; Tajima, O.; Akagawa, K. 1999: HPC-1/syntaxin 1A suppresses exocytosis of PC12 cells. Journal of Biochemistry 125(4): 685-689
Bárdos, J.I.; Saurin, A.J.; Tissot, C.; Duprez, E.; Freemont, P.S. 2000: HPC3 is a new human polycomb orthologue that interacts and associates with RING1 and Bmi1 and has transcriptional repression properties. Journal of Biological Chemistry 275(37): 28785-28792
Chen, J.; Ma, G.X.; Li, D.Q. 1999: HPCPC separation of proteins using polyethylene glycol-potassium phosphate aqueous two-phase. Preparative Biochemistry and Biotechnology 29(4): 371-383
Hann, S.; Zenker, A.; Galanski, M.; Bereuter, T.L.; Stingeder, G.; Keppler, B.K. 2001: HPIC-UV-ICP-SFMS study of the interaction of cisplatin with guanosine monophosphate. Fresenius' Journal of Analytical Chemistry 370(5): 581-586
Liou, J.; Kiefer, F.; Dang, A.; Hashimoto, A.; Cobb, M.H.; Kurosaki, T.; Weiss, A. 2000: HPK1 is activated by lymphocyte antigen receptors and negatively regulates AP-1. Immunity 12(4): 399-408
Pedras, M.S.; Biesenthal, C.J. 2000: HPLC analyses of cultures of Phoma spp.: differentiation among groups and species through secondary metabolite profiles. Canadian Journal of Microbiology 46(8): 685-691
Okada, M.; Kyoguchi, M.; Nakayama, T.; Hirota, R.; Amachi, T.; Ueda, T. 2000: HPLC analysis and optimization of enzymatic synthesis of 4'-O-(beta-D-glucopyranosyl)-D-pantothenic acid. Journal of Nutritional Science and Vitaminology 46(2): 101-104
Nnane, I.P.; Damani, L.A. 2002: HPLC analysis of 4-chlorophenyl methyl sulphide and diphenyl sulphide and their corresponding sulphoxides and sulphones in rat liver microsomes. Journal of Pharmaceutical and Biomedical Analysis 27(1-2): 315-325, 1 January
Chang, K.L.ang B.; Lee, J.; Fu, W.R.ng 2000: HPLC analysis of N-acetyl-chito-oligosaccharides during the acid hydrolysis of chitin. Journal of Food and Drug Analysis 8(2): 75-83
Spell, J.C.; Stewart, J.T. 1999: HPLC analysis of a meropenem-ofloxacin mixture in intravenous solutions using a nonporous octadecylsilane column. Journal of Liquid Chromatography and Related Technologies 22(14): 2225-2234
Lee, M.H.; Kim, E.J.; Kim, S.O.; Lee, D.H.; Lim, H.; Yoo, S.E.; Lee, M.G. 2002: HPLC analysis of a new neuroprotective agent for ischemia-reperfusion damage, a benzopyran derivative, in plasma and urine. Journal of Liquid Chromatography and Related Technologies 25(17): 2679-2685
Yu, S.Y.; Kim, E.J.; Kim, S.O.; Lee, D.H.; Lim, H.; Choi, J.K.; Lee, M.G. 2002: HPLC analysis of a new reversible proton pump inhibitor, a dihydropyrroloquinoline derivative, in plasma, urine, and tissue homogenates. Journal of Liquid Chromatography and Related Technologies 25(17): 2687-2694
Mandal, T.K.; Womack, I. 1999: HPLC analysis of amifostine. Pharmacy and Pharmacology Communications 5(9): 541-543
Koga, D.; Yoshioka, T.; Arakane, Y. 1998: HPLC Analysis of Anomeric Formation and Cleavage Pattern by Chitinolytic Enzyme. Bioscience Biotechnology and Biochemistry 62(8): 1643-1646
D'eramo, F.; Marioli, J.M.; Arevalo, A.A.; Sereno, L.E. 1999: HPLC analysis of carbohydrates with electrochemical detection at a poly-1-naphthylamine/copper modified electrode. Electroanalysis 11(7): 481-486
Noda, M.; Komatsu, H.; Sano, H. 1999: HPLC analysis of dental resin composites components. Journal of Biomedical Materials Research 47(3): 374-378
Okimura, K.; Ohki, K.; Nagai, S.; Sakura, N. 2003: HPLC analysis of fatty acyl-glycine in the aqueous methanesulfonic acid hydrolysates of N-terminally fatty acylated peptides. Biological and Pharmaceutical Bulletin 26(8): 1166-1169
Wang, Y.n; Chen, L.L.n H.; Chien, Yie, W. 1999: HPLC analysis of gonadotropin-releasing hormone and its analogues using benzoin as a fluorogenic reagent. Journal of Liquid Chromatography and Related Technologies 22(16): 2421-2432
Xu, X.; Stewart, J.T. 1999: HPLC analysis of haloperidol and its related compound in the drug substance and a tablet dosage form using a non-porous silica octadecylsilane column. Journal of Liquid Chromatography and Related Technologies 22(12): 1857-1866
Browne, R.W.; Armstrong, D. 2000: HPLC analysis of lipid-derived polyunsaturated fatty acid peroxidation products in oxidatively modified human plasma. Clinical Chemistry 46(6 Pt 1): 829-836
Zhang, Y.; Guo, Y.; Wu, K.; Wang, W. 2003: HPLC analysis of main flavonoid chemicals and their spatio-temporal dynamics in Bt transgenic cotton. Ying Yong Sheng Tai Xue Bao 14(2): 246-248
Tanimoto, T.; Ikuta, A.; Sugiyama, M.; Koizumi, K. 2002: HPLC analysis of manno-oligosaccharides derived from Saccharomyces cerevisiae mannan using an amino column or a graphitized carbon column. Chemical and Pharmaceutical Bulletin 50(2): 280-283
Lengyel, J.; Kalász, H.; Szarvas, T.; Peltz, C.; Szarkáné-Bolehovszky, A. 2003: HPLC analysis of metabolically produced formaldehyde. Journal of Chromatographic Science 41(4): 177-181
Takasaki, A.; Nezirević, D.; Arstrand, K.; Wakamatsu, K.; Ito, S.; Kågedal, B. 2003: HPLC analysis of pheomelanin degradation products in human urine. Pigment Cell Research 16(5): 480-486
Tang, P.H.; Miles, M.V.; DeGrauw, A.; Hershey, A.; Pesce, A. 2001: HPLC analysis of reduced and oxidized coenzyme Q(10) in human plasma. Clinical Chemistry 47(2): 256-265
Mandrioli, R.; Fanali, S.; Ferranti, A.; Raggi, M.A. 2002: HPLC analysis of the novel antipsychotic drug quetiapine in human plasma. Journal of Pharmaceutical and Biomedical Analysis 30(4): 969-977
Sochor, J.; Klimes, J.; Sedlacek, J.; Somolikova, B.; Slovencik, D. 2000: HPLC analysis of tiaprofenic acid in the samples of whole blood using L-L and S-L extractions. Journal of Liquid Chromatography and Related Technologies 23(20): 3191-3201
Fuchs, Jürgen.; Weber, S.; Podda, M.; Groth, N.; Herrling, T.; Packer, L.; Kaufmann, R. 2003: HPLC analysis of vitamin E isoforms in human epidermis: Correlation with minimal erythema dose and free radical scavenging activity. Free Radical Biology and Medicine 34(3): 330-336
Yun, S-Seon.; Scott, A.P.; Bayer, J.M.; Seelye, J.G.; Close, D.A.; Li, W. 2003: HPLC and ELISA analyses of larval bile acids from Pacific and western brook lampreys. Steroids 68(6): 515-523
Aguete, E.C.; Gago-Martínez, A.; Leão, J.M.; Rodríguez-Vázquez, J.A.; Menàrd, C.; Lawrence, J.F. 2003: HPLC and HPCE analysis of microcystins RR, LR and YR present in cyanobacteria and water by using immunoaffinity extraction. Talanta 59(4): 697-705
Ma, M.; DiLollo, A.; Mercuri, R.; Lee, T.; Bundang, M.; Kwong, E. 2002: HPLC and LC-MS studies of the transesterification reaction of methylparaben with twelve 3- to 6-carbon sugar alcohols and propylene glycol and the isomerization of the reaction products by acyl migration. Journal of Chromatographic Science 40(3): 170-177
Henry, J.; Zatylny, C.; Favrel, P. 2000: HPLC and electrospray ionization mass spectrometry as tools for the identification of APGWamide-related peptides in gastropod and bivalve mollusks: Comparative activities on Mytilus muscles. Brain Research 862(1-2): 162-170
Mesplet, N.; Saito, Y.; Morin, P.; Agrofoglio, L.A. 2003: HPLC and mass spectrometry analysis of the enzymatic hydrolysis of anti-HIV pronucleotide diastereomers. Bioorganic Chemistry 31(3): 237-247
Kitzman, D.; Cheng, K-Ju.; Fleckenstein, L. 2002: HPLC assay for albendazole and metabolites in human plasma for clinical pharmacokinetic studies. Journal of Pharmaceutical and Biomedical Analysis 30(3): 801-813
Bobik, T.A.; Rasche, M.E. 2003: HPLC assay for methylmalonyl-CoA epimerase. Analytical and Bioanalytical Chemistry 375(3): 344-349
Franeta, J.T.; Agbaba, D.; Eric, S.; Pavkov, S.; Aleksic, M.; Vladimirov, S. 2002: HPLC assay of acetylsalicylic acid, paracetamol, caffeine and phenobarbital in tablets. Farmaco 57(9): 709-713
Cao-Xiao-Yun; Liu-Hai-Ling; Wei-Xue-Ming 2002: HPLC assay of cefpodoxime proxetil and its preparations. Zhongguo Kangshengsu Zazhi 27(5): 277-279
Ricci, E.; Bentley, M.V.toria Lopes Badra; Marchetti, J.M.ldonado 2002: HPLC assay of lidocaine in in vitro dissolution test of the Poloxamer 407 gels. Revista Brasileira de Ciencias Farmaceuticas 38(1): 107-111
French, D.C.; Saltzgueber, M.; Hicks, D.R.; Cowper, A.L.; Holt, D.W. 2001: HPLC assay with ultraviolet detection for therapeutic drug monitoring of sirolimus. Clinical Chemistry 47(7): 1316-1319
Bongaerts, R.J.M.; Verpoorte, R. 2000: HPLC assays for the chorismate utilizing enzymes chorismate pyruvate lyase and para-aminobenzoate synthase. Journal of Liquid Chromatography and Related Technologies 23(17): 2703-2713
Monedero, L.; Olalla, J.; Quesada, J.J.; Villalon, M.; Garcia Serrana, H.L.; Martinez, C.L. 2000: HPLC characterization of phenolic compounds in commercial aromatic sherry wines. Alimentaria 37(312): 109-114
Chen, D.; Wilhite, T.R.; Smith, C.H.; Blinder, M.A.; Landt, M. 1998: HPLC detection of fetal blood in meconium: improved sensitivity compared with qualitative methods. Clinical Chemistry 44(11): 2277-2280
Vicente-Torres, A.; Bartolomé, M.V.; Carricondo, F.; Esquifino, A.; Gil-Loyzaga, P. 1998: HPLC detection of serotonin within the rat cochlea. Neuroreport 9(16): 3699-3701
Aboul-Enein, H., Y.; Abu-Zaid, S. 2000: HPLC determination of 2-iodomelatonin with fluorescence detection. Journal of Liquid Chromatography and Related Technologies 23(16): 2585-2589
Huang, T.H.; Cheng, H.H.; Tsai, S.Y.; Chao, P.D. Lee; Kuo, S.C. 2001: HPLC determination of 2-phenyl-4-quinolone in rabbit serum. Journal of Liquid Chromatography and Related Technologies 24(1): 79-85
Fang, F.; Xu, G.; Lu, B. 2001: HPLC determination of 4-acetylaminophenylacetic acid. Journal of Liquid Chromatography and Related Technologies 24(7): 1021-1027
Cheng, H.H.; Lin, W.C.; Kuo, S.C.; Huang, T.H.; Tsai, S.Y. 1999: HPLC determination of 9,10-anthraquinone-2-carboxylic acid in serum and its application to pharmacokinetic study. Journal of Food and Drug Analysis 7(3): 199-205
Vishwanathan, K.; Stewart, J.T. 1999: HPLC determination of a propofol and remifentanil mixture. Journal of Liquid Chromatography and Related Technologies 22(6): 923-931
Wang Jian 2000: HPLC determination of a simvastatin and its tablets. Zhongguo Yiyao Gongye Zazhi 31(3): 121-122
Brown, S.D.; White, C.A.; Bartlett, M.G. 2002: HPLC determination of acyclovir and zidovudine in maternal plasma, amniotic fluid, fetal, and placental tissues using ultra-violet detection. Journal of Liquid Chromatography and Related Technologies 25(18): 2857-2871
D.J.lon, E.G.; Campanero, M.A.; Ygartua, P.; Santoyo, S. 2002: HPLC determination of acyclovir in skin layers and percutaneous penetration samples. Journal of Liquid Chromatography and Related Technologies 25(20): 3187-3197
Sottofattori, E.; Anzaldi, M.; Ottonello, L. 2001: HPLC determination of adenosine in human synovial fluid. Journal of Pharmaceutical and Biomedical Analysis 24(5-6): 1143-1146
Herbert, P.; Barros, P.; Ratola, N.; Alves, A. 2000: HPLC determination of amino acids in musts and port wine using OPA/FMOC derivatives. Journal of Food Science 65(7): 1130-1133
Maddox, F.C.; Stewart, J.T. 1999: HPLC determination of an aqueous cefepime and metronidazole mixture. Journal of Liquid Chromatography and Related Technologies 22(18): 2807-2813
Xiong Hui Yan; Zhang Xiao Feng; Wang Huan; Pan Li 2003: HPLC determination of anthraquinones from various parts of R. Tanguticum, R. undulatum and R. spiciforme. Xibei Zhiwu Xuebao 23(2): 328-331
Volckova, E.; Dudones, L.P.; Bose, R.N. 2002: HPLC determination of binding of cisplatin to DNA in the presence of biological thiols: Implications of dominant platinum-thiol binding to its anticancer action. Pharmaceutical Research 19(2): 124-131
Sri Kantha, S.; Takeuchi, M.; Watabe, S.; Ochi, H. 2000: HPLC determination of carnosine in commercial canned soups and natural meat extracts. Lebensmittel-Wissenschaft + Technologie 33(1): 60-62
L.Y.P.ng; Zhou Zhao Hui; Deng, J.Q.ng 1999: HPLC determination of ciclosporin capsules. Zhongguo Yiyao Gongye Zazhi 29(12): 556-557
Wang-Jian; Zhang-Hua 2000: HPLC determination of ciclosporin oral solution. Zhongguo Kangshengsu Zazhi 25(1): 22-23
Sun-Jin; Chen-Feng; Wang-Shu-Jun; Zhang-Wei; Chen-Ji-Min 2002: HPLC determination of ciprofloxacin with fluorescence detection in rat plasma and its pharmacokinetics study. Zhongguo Kangshengsu Zazhi 27(10): 625-627, 640
Xia, Z.H.; Huang, L.J.; Wei, X.P. 1998: HPLC determination of clindamycin phosphate gel. Zhongguo Yiyao Gongye Zazhi 29(11): 515-516
Gagliardi, L.[author, Reprint-Author]; De-Orsi, D.[author, Reprint-Author]; Manna, F.; Tonelli, D. 2000: HPLC determination of clobetasol propionate in cosmetic products. Journal of Liquid Chromatography and Related Technologies 23(3): 355-362
Borner, K.; Hartwig, H.; Leitzke, S.; Hahn, H.; Müller, R.H.; Ehlers, S. 1999: HPLC determination of clofazimine in tissues and serum of mice after intravenous administration of nanocrystalline or liposomal formulations. International Journal of Antimicrobial Agents 11(1): 75-79
Yu-Cai-Yan; Li-Ming-Hua; Wu-Xian-Fang; Cui-Jing-Hua; An-Li-Yan 1999: HPLC determination of dechlorogriseofulvin in griseofulvin. Zhongguo Yiyao Gongye Zazhi 30(10): 459-460
Pan, X.Q.; Zhang, Y.Y. 1999: HPLC determination of doxazosin tablets. Zhongguo Yiyao Gongye Zazhi 30(7): 317-318
Wu, S.M.; Wang, Y.X. 1998: HPLC determination of ephedrine hydrochloride in ZhengKeNing syrup. Zhongguo Yiyao Gongye Zazhi 29(10): 468-469
Kartinasari, W.F.; Chufianty, H.; Indrayanto, G. 2003: HPLC determination of flunarizine dihydrochloride in tablets and its validation. Journal of Liquid Chromatography and Related Technologies 26(7): 1059-1067
Wilcox, M.L.; Stewart, J.T. 2000: HPLC determination of guaifenesin with selected medications on underivatized silica with an aqueous-organic mobile phase. Journal of Pharmaceutical and Biomedical Analysis 23(5): 909-916
Wang Jian; Huang Zong Yu 1999: HPLC determination of lomefloxacin and its capsules. Zhongguo Yiyao Gongye Zazhi 30(5): 218-219
Nozal, M.J.; Bernal, J.L.; Diego, J.C.; Gomez, L.A.; Higes, M. 2003: HPLC determination of low molecular weight organic acids in honey with series-coupled ion-exclusion columns. Journal of Liquid Chromatography and Related Technologies 26(8): 1231-1253
Yang-Si-Li; Li-Shi-Cai 1999: HPLC determination of mezlocillin sodium. Zhongguo Yiyao Gongye Zazhi 30(5): 219-221
L.Min Li 1999: HPLC determination of moclobemide and its tablets. Zhongguo Yiyao Gongye Zazhi 29(12): 557-559
Nakashima, K.; Kanehara, S.; Kaddoumi, A. 2002: HPLC determination of phenylpropanolamine in pharmaceutical OTC preparations. Biomedical Chromatography: Bmc 16(7): 463-469
Rind, F.M.; Khuhawar, M.Y.; Rajper, A.D. 2001: HPLC determination of phenylpropanolamine in pharmaceutical preparations using 4-dimethylaminobenzaldehyde as a derivatizing reagent. Journal of Pharmaceutical and Biomedical Analysis 26(2): 331-336
Yu, P.; Yao, L.; Wang, L. 1998: HPLC determination of podophyllotoxin in four dysosma plants. Acta Academiae Medicinae Shanghai 25(6): 452-453
Wei, L.P.; Jiang Xiong Ping 1999: HPLC determination of residual quantity of ampicillin in rhIL-2. Zhongguo Yiyao Gongye Zazhi 30(6): 267-269
Dornberger, K.; Kruegel, H.; Peschel, G. 2001: HPLC determination of the major factors of the nourseothricin complex, an antibiotic for nonmedical uses. Journal of Liquid Chromatography and Related Technologies 24(8): 1153-1159
Zhang, Xiu Ling 1998: HPLC determination of ticlopidine hydrochloride, its capsules and tablets. Zhongguo Yiyao Gongye Zazhi 29(10): 459-460
Zhu, B.W.; Yuan, G.P.; Jin, N.B. 1998: HPLC determination of tosufloxacin tosylate. Zhongguo Yiyao Gongye Zazhi 29(11): 512-513
Zhang, Q.S.; Bai, Z.Z.; Sun, J. 1998: HPLC determination of tretinoin soft capsules. Zhongguo Yiyao Gongye Zazhi 29(11): 513-515
Liu-Lifang; Jin-Rongluan; Xu-Guojun 1999: HPLC determination of uracil xanthine, hypoxanthine and uridine in ten species of animal drugs. Zhongguo Zhongyao Zazhi 24(2): 73-76;124
Chen Shi Feng; Jiang Yan; Cao Quan Sheng 1999: HPLC determination of vitamin B6 in albendazol chewable tablets. Zhongguo Yiyao Gongye Zazhi 30(2): 76-78
D'andrea, G.; Terrazzino, S.; Fortin, D.; Farruggio, A.; Rinaldi, L.; Leon, A. 2003: HPLC electrochemical detection of trace amines in human plasma and platelets and expression of mRNA transcripts of trace amine receptors in circulating leukocytes. Neuroscience Letters 346(1-2): 89-92
Aboul-Enein, H.Y.; Ali, I. 2001: HPLC enantiomeric resolution of nebivolol on normal and reversed amylose based chiral phases. Die Pharmazie 56(3): 214-216
Aboul-Enein, H.Y.; Ali, I.; Gübitz, G.; Simons, C.; Nicholls, P.J. 2000: HPLC enantiomeric resolution of novel aromatase inhibitors on cellulose- and amylose-based chiral stationary phases under reversed phase mode. Chirality 12(10): 727-733
Aboul Enein, H.Y.; Abu Zaid, S. 2002: HPLC enantiomeric resolution of novel tetralone derivatives on cellulose and amylose based chiral stationary phases under normal phase mode. Journal of Liquid Chromatography and Related Technologies 25(7): 1077-1084
Dolezalova, M.; Tkaczykova, M. 1999: HPLC enantioselective separation of aromatic amino and hydrazino acids on a teicoplanin stationary phase and the enantiomeric purity determination of L-isomers used as drugs. Chirality 11(5-6): 394-403
Kumaria, N.; Dwivedi, A.K.; Singh, S. 1999: HPLC estimation method of a new spermicidal and anti HIV compound 1-(4-methoxy phenyl),5-piperidino penta-1,4-diene-3-one in its dosage form. Indian Journal of Pharmaceutical Sciences 61(3): 184-186
Klimes, J.; Sochor, J.; Dolezal, P.; Körner, J. 2001: HPLC evaluation of diclofenac in transdermal therapeutic preparations. International Journal of Pharmaceutics 217(1-2): 153-160
Laviana, L.; Fernández-Marí, F.; Bayod, M.; Blanco, D. 2003: HPLC for in-process control in the production of sultamicillin. Journal of Pharmaceutical and Biomedical Analysis 31(2): 321-328
Rizova, V.; Stafilov, T.; Stojanoski, K. 1999: HPLC investigation of the degradation of some artificial food colorants in the presence of ascorbic acid. Acta Pharmaceutica 49(3): 211-216
Wang, Y. 2002: HPLC isolation and mass spectrometric characterization of two isomers of thymine glycols in oligodeoxynucleotides. Chemical Research in Toxicology 15(5): 671-676
Ng, J.C.; Qi, L.; Moore, M.R. 2002: HPLC measurement of harderoporphyrin in the harderian glands of rodents as a biomarker for sub-lethal or chronic arsenic exposure. Toxicology Letters 133(1): 93-101
Kalnovicova, T.; Diveky, L.; Turcani, P. 2001: HPLC measurement of purine nucleotide degradation products in amniotic fluid and its use in prenatal diagnosis. Journal of Trace and Microprobe Techniques 19(1): 171-176
Spacek, P.; Adam, M. 2002: HPLC method for pentosidine determination in urine, serum, and tissues as a marker of glycation and oxidation loading of the organism. Journal of Liquid Chromatography and Related Technologies 25(12): 1807-1820
Bi, M.; Singh, J. 1999: HPLC method for quantification of arginine containing vasopressin. Journal of Liquid Chromatography and Related Technologies 22(4): 551-560
Xu, X.; Stewart, J.T. 2000: HPLC methods for aspirin-caffeine-butalbital and acetaminophen-caffeine-butalbital mixtures in tablet dosage forms using non-porous octadecylsilane columns. Journal of Liquid Chromatography and Related Technologies 23(5): 769-779
Park, K.M.; Lee, M.K.; Park, Y.H.; Woo, J.S.; Kim, C.K. 2001: HPLC of acetyl-L-carnitine in human plasma by derivatization with p-bromophenacyl bromide. Journal of Liquid Chromatography and Related Technologies 24(4): 555-563
Flanagan, R.J.; Harvey, E.J.; Spencer, E.P. 2001: HPLC of basic drugs on microparticulate strong cation-exchange materials - a review. Forensic Science International 121(1-2): 97-102
Xiao, Y.-Xiu; Xiao, Xiang-Zhu; Feng, Y.-Qi; Wang, Zhong-Hua; Da, Shi-Lu 2001: HPLC of some nucleosides and bases on p-tert-butyl-calix(6)arene-bonded silica gel stationary phase. Journal of Liquid Chromatography and Related Technologies 24(19): 2925-2942
Zarghi, A.; Dadashzadeh, S.; Ebrahimian, A.J. 2000: HPLC quantification of diltiazem in plasma from man. Pharmacy and Pharmacology Communications 6(8): 341-343
Morin, N.; Cornet, S.; Guinchard, C.; Rouland, J.C.; Guillaume, Y.C. 2000: HPLC retention and inclusion of imidazole derivatives using hydroxypropyl-beta-cyclodextrin as a mobile phase additive. Journal of Liquid Chromatography and Related Technologies 23(5): 727-739
Gau, F.; Bres, J.; Cupissol, D.; Gory-Delabaere, G.; Nouguier-Soule, J. 1999: HPLC saliva vinorelbine (Navelbine(R)) assay validation: Concentrations in cancer patients. Journal de Pharmacie Clinique 18(SPEC. ISSUE): 62-64
Joshi, S. 2002: HPLC separation of antibiotics present in formulated and unformulated samples. Journal of Pharmaceutical and Biomedical Analysis 28(5): 795-809
Bielejewska, A.; Sinibaldi, M.; Grynkiewicz, G.; Kutner, A. 1999: HPLC separation of enantiomers of bromofosfamide and its metabolites using a chiral stationary phase. Pharmacy and Pharmacology Communications 5(9): 537-539
Kiyoshima, A.; Kudo, K.; Nishida, N.; Ikeda, N. 2002: HPLC simultaneous determination of glycerol and mannitol in human tissues for forensic analysis. Forensic Science International 125(2-3): 127-133
Szasz, G.; Takacs Novak, K.; Kokosi, J. 2001: HPLC study on ion-pairing ability of deoxycholic acid epimers. Journal of Liquid Chromatography and Related Technologies 24(2): 173-185
Anonymous 1999: HPLC use for analysis isobutyl ester of retinoid acid. Farmatsiya 48(4): 26-27
Arkhapchev, J.P.; Guzev, K.S.; Sazikina, L.N.; Nozdrin, V.I.; Evtushenko, N.S. 1999: HPLC use for pharmacokinetic investigations of 13-cis-retinoic acid containing in drug forms. Farmatsiya 48(1): 13-15
Muellner, C.; Sontag, G. 2000: HPLC with coulometric electrode array detection: Determination of daidzein and genistein in soy based infant food, soy milk and soy based supplements. European Food Research and Technology 211(4): 301-304
Kotani, A.; Kusu, F. 2002: HPLC with electrochemical detection for determining the distribution of free fatty acids in skin surface lipids from the human face and scalp. Archives of Dermatological Research 294(4): 172-177
Kaufmann, A.; Ryser, B.; Suter, B. 2001: HPLC with evaporative light scattering detection for the determination of polar compounds in used frying oils. European Food Research and Technology 213(4-5): 372-376
Savu, S.; Mitrea, M.; Silvestro, L.; Mancini, C. 2000: HPLC with on-line mass spectrometry detection application to elucidate erdosteine metabolism: preliminary study. International Journal of Clinical Pharmacology and Therapeutics 38(8): 415-417
Tache, F.; David, V.; Farca, A.; Medvedovici, A. 2001: HPLC-DAD determination of Metformin in human plasma using derivatization with p-nitrobenzoyl chloride in a biphasic system. Microchemical Journal 68(1): 13-19
Kaminski, M.; Kartanowicz, R.; Kaminski, M.M.; Krolicka, A.; Sidwa Gorycka, M.; Lojkowska, E.; Gorzen, W. 2003: HPLC-DAD in identification and quantification of selected coumarins in crude extracts from plant cultures of Ammi majus and Ruta graveolens. Journal of Separation Science 26(14): 1287-1291
Nassr, S.; Brunet, M.; Lavoie, P.; Brazier, J.L. 2001: HPLC-DAD method for studying the stability of solutions containing Morphine, Dexamethasone, Haloperidol, Midazolam, Famotidine, Metoclopramide, and Dimenhydrinate. Journal of Liquid Chromatography and Related Technologies 24(2): 265-281
Cosentino, M.; Bombelli, R.; Ferrari, M.; Marino, F.; Rasini, E.; Maestroni, G.J.M.; Conti, A.; Boveri, M.; Lecchini, S.; Frigo, G. 2000: HPLC-ED measurement of endogenous catecholamines in human immune cells and hematopoietic cell lines. Life Sciences 68(3): 283-295
Xie, J-bo.; Bi, Z-ming.; Li, P. 2003: HPLC-ELSD determination of triterpenoids and triterpenoid saponins in Ilex pupurea leaves. Yao Xue Xue Bao 38(7): 534-536
Kollroser, M.; Henning, G.; Gatternig, R.; Schober, C. 2001: HPLC-ESI-MS/MS determination of zuclopenthixol in a fatal intoxication during psychiatric therapy. Forensic Science International 123(2-3): 243-247
Van den Bergh, V.; Coeckelberghs, H.; Vanhees, I.; De Boer, R.; Compernolle, F.; Vinckier, C. 2002: HPLC-MS determination of the oxidation products of the reaction between alpha- and beta-pinene and OH radicals. Analytical and Bioanalytical Chemistry 372(5-6): 630-638
Chithalen, J.V.; Luu, L.; Petkovich, M.; Jones, G. 2002: HPLC-MS/MS analysis of the products generated from all-trans-retinoic acid using recombinant human CYP26A. Journal of Lipid Research 43(7): 1133-1142
Holscher, D.S.hneider, B. 1999: HPLC-NMR analysis of phenylphenalenones and a stilbene from Anigozanthos flavidus. Phytochemistry 50(1): 155-161
Rózyło, T.K.; Siembida, R.; Nemeth, Z.I.; Albert, L.; Tyihak, E. 2000: HPLC-OPLC-MS investigation of change of formaldehyde and its generators in human teeth of different physiological stage. Biomedical Chromatography: Bmc 14(3): 173-179
Williamson, K.S.; Petty, J.D.; Huckins, J.N.; Lebo, J.A.; Kaiser, E.M. 2002: HPLC-PFD determination of priority pollutant PAHs in water, sediment, and semipermeable membrane devices. Chemosphere 49(7): 703-715
Nuijen, B.; Rodrigues Campos, I.M.; Noain, C.P.; Floriano, P.; Manada, C.; Bouma, M.; Kettenes Van Den Bosch, J.J.; Bult, A.; Beijnen, J.H. 2001: HPLC-UV method development and impurity profiling of the marine anticancer agent aplidine in raw drug substance and pharmaceutical dosage form. Journal of Liquid Chromatography and Related Technologies 24(20): 3119-3139
Pineiro-Iglesias, M.; Vazquez-Blanco, E.; Lopez-Mahia, P.; Muniategui-Lorenzo, S.; Prada-Rodriguez, D. 2000: HPLC-UV-FL PAH analysis in air particulates; application to La Coruna (Spain) air samples. Annali di Chimica 90(5-6): 379-388
do Nascimento, P.C.; Bohrer, D.; Rohlfes, A.L.; de Carvalho, L.M.; Ramirez, A. 2001: HPLC-based method using sample pre-column clean-up for the determination of methanethiol and ethanethiol in parenteral amino acid solutions. Fresenius' Journal of Analytical Chemistry 370(1): 92-96
Choi, Y.Hae.; Yoo, K-Pung.; Kim, J. 2003: HPLC-electrospray ionization-MS-MS analysis of Cephalotaxus harringtonia leaves and enhancement of the extraction efficiency of alkaloids therein by SFE. Journal of Chromatographic Science 41(2): 67-72
Yoon, Y.; Westerhoff, P.; Snyder, S.A.; Esparza, M. 2003: HPLC-fluorescence detection and adsorption of bisphenol A, 17beta-estradiol, and 17alpha-ethynyl estradiol on powdered activated carbon. Water Research 37(14): 3530-3537
Gatti, R.; Franchina, M.; Gioia, M.G.; Cavrini, V. 2000: HPLC-fluorescence determination of equilin and equilenin in postmenopausal women's urine. Biomedical Chromatography: Bmc 14(2): 82-88
Gatti, R.; Gioia, M.G.; Di Pietra, A.M.; Cavrini, V. 1998: HPLC-fluorescence determination of unconjugated estrogens in pharmaceuticals. Journal of Pharmaceutical and Biomedical Analysis 18(1-2): 187-192
Zhang, H.; Yu, C.; Liu, G-yi.; Jia, J-ying.; Hong, Y-cai.; Xu, X-rong. 2003: HPLC-fluorescent spectrometric determination of serum mexiletine concentration after derivatization with fluram. Yao Xue Xue Bao 38(3): 215-217
Corcoran, O.; Mortensen, R.W.; Hansen, S.H.; Troke, J.; Nicholson, J.K. 2001: HPLC/1H NMR spectroscopic studies of the reactive alpha-1-O-acyl isomer formed during acyl migration of S-naproxen beta-1-O-acyl glucuronide. Chemical Research in Toxicology 14(10): 1363-1370
Madej, K.; Parczewski, A.; Kała, M. 2003: HPLC/DAD Screening Method for Selected Psychotropic Drugs in Blood. Toxicology Mechanisms and Methods 13(2): 121-127
Gruemping, R.; Hirner, A.V. 1999: HPLC/ICP-OES determination of water-soluble silicone (PDMS) degradation products in leachates. Fresenius' Journal of Analytical Chemistry 363(4): 347-352
Tracqui, A.; Kintz, P.; Mangin, P. 1997: HPLC/MS determination of buprenorphine and norbuprenorphine in biological fluids and hair samples. Journal of Forensic Sciences 42(1): 111-114
Combs, M.T.; Asharf Khorassani, M.; Taylor, L.T. 1999: HPLC/atmospheric pressure chemical ionization-mass spectroscopy of eight regulated sulfonamides. Journal of Pharmaceutical and Biomedical Analysis 19(3-4): 301-308
Casal, S.; Oliveira, M.B.; Ferreira, M.A. 2000: HPLC/diode-array applied to the thermal degradation of trigonelline, nicotinic acid and caffeine in coffee. Food Chemistry 68(4): 481-485
Pavanello, S.; Favretto, D.; Brugnone, F.; Mastrangelo, G.; Dal Pra, G.; Clonfero, E. 1999: HPLC/fluorescence determination of anti-BPDE-DNA adducts in mononuclear white blood cells from PAH-exposed humans. Carcinogenesis 20(3): 431-435
Gianasi, E.; Wasil, M.; Evagorou, E.G.; Keddle, A.; Wilson, G.; Duncan, R. 1999: HPMA copolymer platinates as novel antitumour agents: In vitro properties, pharmacokinetics and antitumour activity in vivo. European Journal of Cancer 35(6): 994-1002
Kopecek, J.; Kopecková, P.; Minko, T.; Lu, Z. 2000: HPMA copolymer-anticancer drug conjugates: Design, activity, and mechanism of action. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik E.V 50(1): 61-81
Hart, P.R.; Kopecková, P.; Omelyanenko, V.; Enioutina, E.; Kopecek, J. 2000: HPMA copolymer-modified avidin: immune response. Journal of Biomaterials Science. Polymer Edition 11(1): 1-12
St'astný, M.; Plocová, D.; Etrych, Tás.; Kovár, M.; Ulbrich, K.; Ríhová, B. 2002: HPMA-hydrogels containing cytostatic drugs. Kinetics of the drug release and in vivo efficacy. Journal of Controlled Release: Official Journal of the Controlled Release Society 81(1-2): 101-111
St'astný, M.; Plocová, D.; Etrych, T.; Ulbrich, K.; Ríhová, B. 2002: HPMA-hydrogels result in prolonged delivery of anticancer drugs and are a promising tool for the treatment of sensitive and multidrug resistant leukaemia. European Journal of Cancer 38(4): 602-608
Siepmann, J.; Kranz, H.; Bodmeier, R.; Peppas, N.A. 1999: HPMC-matrices for controlled drug delivery: A new model combining diffusion, swelling, and dissolution mechanisms and predicting the release kinetics. Pharmaceutical Research 16(11): 1748-1756
Garneau, M.; Bolger, G.T.; Bousquet, C.; Kibler, P.; Tremblay, Fçois.; Cordingley, M.G. 2003: HPMPC therapy of MCMV-induced retinal disease in the SCID mouse measured by electroretinography, a non-invasive technique. Antiviral Research 59(3): 193-200
Nikolova, T.; Benova, D. 2000: HPRT mutant and chromosome aberration frequencies in peripheral blood lymphocytes of females environmentally exposed to radon and radon progeny. Genetics and Breeding 30(1-2): 3-10
Huo, L.; Nagasawa, H.; Little, J.B. 2001: HPRT mutants induced in bystander cells by very low fluences of alpha particles result primarily from point mutations. Radiation Research 156(5 Pt 1): 521-525
Albertini, R.J. 2001: HPRT mutations in humans: Biomarkers for mechanistic studies. Mutation Research 489(1): 1-16
Eidam, P.M.; Schariter, J.J.; Fried, B.; Sherma, J. 2001: HPTLC analysis of tissue and blood of Biomphalaria glabrata snails to assess the effects of a diet of romaine lettuce leaf versus midrib on the concentrations of lipids, pigments, and carbohydrates. Journal of Liquid Chromatography and Related Technologies 24(10): 1467-1478
Jamshidi, A.; Adjvadi, M.; Shahmiri, S.; Massoumi, A. 2000: HPTLC assay for ibuprofen in newly formulated liquorice-containing tablets. Journal of Planar Chromatography - Modern TLC 13(1): 45-47
Eric Jovanovic, S.; Agbaba, D.; Zivanov Stakic, D.; Vladimirov, S. 1998: HPTLC determination of ceftriaxone, cefixime and cefotaxime in dosage forms. Journal of Pharmaceutical and Biomedical Analysis 18(4-5): 893-898
Lala, L.G.; D'mello, P.M.; Naik, S.R. 2002: HPTLC determination of diclofenac sodium from serum. Journal of Pharmaceutical and Biomedical Analysis 29(3): 539-544
Devarajan, P.V.; Gore, S.P.; Chavan, S.V. 2000: HPTLC determination of ketorolac tromethamine. Journal of Pharmaceutical and Biomedical Analysis 22(4): 679-683
Badami, S.; Gupta, M.K.; Mathew, N.; Meyyanathan, S.N.; Suresh, B.; Bendell, D.J. 2002: HPTLC determination of lupeol in Grewia tiliaefolia. Journal of Planar Chromatography - Modern TLC 15(3): 183-186
Patravale, V.B.; D'souza, S.; Narkar, Y. 2001: HPTLC determination of nimesulide from pharmaceutical dosage forms. Journal of Pharmaceutical and Biomedical Analysis 25(3-4): 685-688
Marutsenko, I.V.; Polenova, T.V.; Virus, E.D.; Borzenko, A.G.; Revelsky, I.A. 2001: HPTLC determination of polyaromatic hydrocarbons in smokers' hair. Journal of Planar Chromatography - Modern TLC 14(5): 330-333
Dubhashi, S.S.; Vavia, P.R. 2000: HPTLC method to study skin permeation of acylovir. Journal of Pharmaceutical and Biomedical Analysis 23(6): 1017-1022
Baez, M.V.; Robinsohn, A.E.; Legaspi, M.J.; Hedrera, M.E.; Fernandez, B.M. 2003: HPTLC monitoring of the biocatalytic synthesis of quinoxalinone derivatives in a one-pot reaction. Journal of Planar Chromatography - Modern TLC 16(1): 28-31
Sawicka, U.; Cisowski, W.; Matysik, G.; Kowalczyk, A. 2002: HPTLC of phenolic acids in Bistortae rhizoma, Polygoni avicularis herba, Rhei radix with densitometric. determination. Journal of Planar Chromatography - Modern TLC 15(6): 442-448
Narvekar, M.S.; Srivastava, A.K. 2001: HPTLC separation and determination of banned amine isomers, with reference to the German ban on azo dyes. Journal of Planar Chromatography - Modern TLC 14(5): 360-363
Varshney, Krishan Murari 2002: HPTLC study of the stability of heroin in methanol. Journal of Planar Chromatography - Modern TLC 15(1): 46-49
Rajani, M.; Ravishankara, M.N.; Shrivastava, N.; Padh, H. 2001: HPTLC-aided phytochemical fingerprinting analysis as a tool for evaluation of herbal drugs. A case study of ushaq (ammoniacum gum). Journal of Planar Chromatography Modern TLC 14(1): 34-41
Kopelent Frank, H.; Schimper, A. 1999: HPTLC-based stability assay for the determination of amiodarone in intravenous admixtures. Pharmazie 54(7): 542-544
Duerksen-Hughes, P.J.; Yang, J.; Schwartz, S.B. 1999: HPV 16 E6 blocks TNF-mediated apoptosis in mouse fibroblast LM cells. Virology 264(1): 55-65
Strickler, H.D.; Kirk, G.D.; Figueroa, J.P.; Ward, E.; Braithwaite, A.R.; Escoffery, C.; Drummond, J.; Goebel, B.; Waters, D.; McClimens, R.; Manns, A. 1999: HPV 16 antibody prevalence in Jamaica and the United States reflects differences in cervical cancer rates. International Journal of Cancer 80(3): 339-344
Kawamata, Y.; Mitsuhashi, A.; Unno, Y.; Kado, S.; Shino, Y.; Uesugi, K.; Eguchi, O.; Ishii, J.; Seki, K.; Sekiya, S.; Shirasawa, H. 2002: HPV 16-E6-mediated degradation of intrinsic p53 is compensated by upregulation of p53 gene expression in normal cervical keratinocytes. International Journal of Oncology 21(3): 561-567
Baron, J.M.; Rübben, A.; Grussendorf-Conen, E.I. 1999: HPV 18-induced pigmented bowenoid papulosis of the neck. Journal of the American Academy of Dermatology 40(4): 633-634
Samama, B.; Plas-Roser, Sé.; Schaeffer, C.; Chateau, D.; Fabre, M.; Boehm, N. 2002: HPV DNA detection by in situ hybridization with catalyzed signal amplification on thin-layer cervical smears. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 50(10): 1417-1420
Schiffman, M.; Herrero, R.; Hildesheim, A.; Sherman, M.E.; Bratti, M.; Wacholder, S.; Alfaro, M.; Hutchinson, M.; Morales, J.; Greenberg, M.D.; Lorincz, A.T. 2000: HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA 283(1): 87-93
Wright, T.C.; Denny, L.; Kuhn, L.; Pollack, A.; Lorincz, A. 2000: HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 283(1): 81-86
Stentella, P.; Frega, A.; Ciccarone, M.; Cipriano, L.; Tinari, A.; Tzantzoglou, S.; Pachì, A. 1998: HPV and intraepithelial neoplasia recurrent lesions of the lower genital tract: assessment of the immune system. European Journal of Gynaecological Oncology 19(5): 466-469
Sehr, P.; Müller, M.; Höpfl, R.; Widschwendter, A.; Pawlita, M. 2002: HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. Journal of Virological Methods 106(1): 61-70
Hildesheim, A.; Herrero, R.; Castle, P.E.; Wacholder, S.; Bratti, M.C.; Sherman, M.E.; Lorincz, A.T.; Burk, R.D.; Morales, J.; Rodriguez, A.C.; Helgesen, K.; Alfaro, M.; Hutchinson, M.; Balmaceda, I.; Greenberg, M.; Schiffman, M. 2001: HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. British Journal of Cancer 84(9): 1219-1226
Lanham, S.; Herbert, A.; Watt, P. 2001: HPV detection and measurement of HPV-16, telomerase, and survivin transcripts in colposcopy clinic patients. Journal of Clinical Pathology 54(4): 304-308
Dybikowska, A.; Licznerski, P.; Podhajska, A. 2002: HPV detection in cervical cancer patients in northern Poland. Oncology Reports 9(4): 871-874
Stoler, M.H. 2001: HPV for cervical cancer screening: is the era of the molecular pap smear upon us?. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 49(9): 1197-1198
Huang, C.C.; Kashima, M.L.; Chen, H.; Shih, I.M.; Kurman, R.J.; Wu, T.C. 1999: HPV in situ hybridization with catalyzed signal amplification and polymerase chain reaction in establishing cerebellar metastasis of a cervical carcinoma. Human Pathology 30(5): 587-591
French, D.; Cermele, C.; Vecchione, A.; Cenci, M.; Vecchione, A. 2000: HPV infection and microsatellite instability in squamous lesions of the uterine cervix. Anticancer Research 20(5b): 3417-3421
Syrjänen, K.J. 2002: HPV infections and lung cancer. Journal of Clinical Pathology 55(12): 885-891
Syrjänen, K.J. 2002: HPV infections and oesophageal cancer. Journal of Clinical Pathology 55(10): 721-728
Syrjänen, K.J. 2003: HPV infections in benign and malignant sinonasal lesions. Journal of Clinical Pathology 56(3): 174-181
Woodworth, C.D. 2002: HPV innate immunity. Frontiers in Bioscience: a Journal and Virtual Library 7: D2058-D2071
Hennig, E.M.; Suo, Z.; Karlsen, F.; Holm, R.; Thoresen, S.; Nesland, J.M. 1999: HPV positive bronchopulmonary carcinomas in women with previous high-grade cervical intraepithelial neoplasia (CIN III). Acta Oncologica 38(5): 639-647
Zielinski, G.D.; Snijders, P.J.; Rozendaal, L.; Voorhorst, F.J.; van der Linden, H.C.; Runsink, A.P.; de Schipper, F.A.; Meijer, C.J. 2001: HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears. British Journal of Cancer 85(3): 398-404
Strand, A.; Andersson, S.; Zehbe, I.; Wilander, E. 1999: HPV prevalence in anal warts tested with the MY09/MY11 SHARP Signal system. Acta Dermato-Venereologica 79(3): 226-229
Brown, M.R.; Noffsinger, A.; First, M.R.; Penn, I.; Husseinzadeh, N. 2000: HPV subtype analysis in lower genital tract neoplasms of female renal transplant recipients. Gynecologic Oncology 79(2): 220-224
Mikaelsdottir, E.K.; Benediktsdottir, K.R.; Olafsdottir, K.; Arnadottir, T.; Ragnarsson, G.B.; Olafsson, K.; Sigurdsson, K.; Kristjansdottir, G.S.; Imsland, A.K.; Ogmundsdottir, H.M.; Rafnar, T. 2003: HPV subtypes and immunological parameters of cervical cancer in Iceland during two time periods, 1958-1960 and 1995-1996. Gynecologic Oncology 89(1): 22-30
Bauer, M.; Wagner, H.; Lipford, G.B. 2000: HPV type 16 protein E7 HLA-A2 binding peptides are immunogenic but not processed and presented. Immunology Letters 71(1): 55-59
Santos, C.; Muñoz, N.; Klug, S.; Almonte, M.; Guerrero, I.; Alvarez, M.; Velarde, C.; Galdos, O.; Castillo, M.; Walboomers, J.; Meijer, C.; Caceres, E. 2001: HPV types and cofactors causing cervical cancer in Peru. British Journal of Cancer 85(7): 966-971
Hu, X.; Guo, Z.; Tianyun, P.; Pontén, F.; Wilander, E.; Andersson, S.; Pontén, J. 1999: HPV typing and HPV16 E6-sequence variations in synchronous lesions of cervical squamous-cell carcinoma from Swedish patients. International Journal of Cancer 83(1): 34-37
Graham, D.A.; Herrington, C.S. 2000: HPV-16 E2 gene disruption and sequence variation in CIN 3 lesions and invasive squamous cell carcinomas of the cervix: relation to numerical chromosome abnormalities. Molecular Pathology: Mp 53(4): 201-206
Kim, H.J.; Guo, W.; Park, N.H. 2000: HPV-16 E6 oncoprotein induces mutations via p53-dependent and -independent pathways. Oncology Reports 7(4): 707-712
Simbulan-Rosenthal, C.M.; Velena, A.; Veldman, T.; Schlegel, R.; Rosenthal, D.S. 2002: HPV-16 E6/7 immortalization sensitizes human keratinocytes to ultraviolet B by altering the pathway from caspase-8 to caspase-9-dependent apoptosis. Journal of Biological Chemistry 277(27): 24709-24716
Le Buanec, H.; D'Anna, R.; Lachgar, A.; Zagury, J.F.; Bernard, J.; Ittelé, D.; d'Alessio, P.; Hallez, S.; Giannouli, C.; Burny, A.; Bizzini, B.; Gallo, R.C.; Zagury, D. 1999: HPV-16 E7 but not E6 oncogenic protein triggers both cellular immunosuppression and angiogenic processes. Biomedicine and PharmacoTherapy 53(9): 424-431
Boxman, I.L.; Mulder, L.H.; Vermeer, B.J.; Bavinck, J.N.; ter Schegget, J.; Ponec, M. 2000: HPV-DNA is not detectable in outgrowing cells from explant cultures of skin lesions established at the air-liquid-interface. Journal of Medical Virology 61(3): 281-288
Womack, S.D.; Chirenje, Z.M.; Gaffikin, L.; Blumenthal, P.D.; McGrath, J.A.; Chipato, T.; Ngwalle, S.; Munjoma, M.; Shah, K.V. 2000: HPV-based cervical cancer screening in a population at high risk for HIV infection. International Journal of Cancer 85(2): 206-210
Del Mistro, A.; Chieco Bianchi, L. 2001: HPV-related neoplasias in HIV-infected individuals. European Journal of Cancer 37(10): 1227-1235
Weijzen, S.; Zlobin, A.; Braid, M.; Miele, L.; Kast, W.M. 2003: HPV16 E6 and E7 oncoproteins regulate Notch-1 expression and cooperate to induce transformation. Journal of Cellular Physiology 194(3): 356-362
Luxton, J.; Mant, C.; Greenwood, B.; Derias, N.; Nath, R.; Shepherd, P.; Cason, J. 2000: HPV16 E6 oncogene variants in women with cervical intraepithelial neoplasia. Journal of Medical Virology 60(3): 337-341
Alfandari, J.; Shnitman Magal, S.; Jackman, A.; Schlegel, R.; Gonen, P.; Sherman, L. 1999: HPV16 E6 oncoprotein inhibits apoptosis induced during serum-calcium differentiation of foreskin human keratinocytes. Virology 257(2): 383-396
Kaufmann, A.M.; Nieland, J.; Schinz, M.; Nonn, M.; Gabelsberger, J.; Meissner, H.; Müller, R.T.; Jochmus, I.; Gissmann, L.; Schneider, A.; Dürst, M. 2001: HPV16 L1E7 chimeric virus-like particles induce specific HLA-restricted T cells in humans after in vitro vaccination. International Journal of Cancer 92(2): 285-293
Badaracco, G.; Venuti, A.; Sedati, A.; Marcante, M.L. 2002: HPV16 and HPV18 in genital tumors: Significantly different levels of viral integration and correlation to tumor invasiveness. Journal of Medical Virology 67(4): 574-582
Cimoli, G.; Valenti, M.; Ottoboni, C.; Parodi, S. 2001: HPV16-E6 enhances mitoxantrone sensitivity in a human ovarian cancer line: an isolated instance or a trend?. International Journal of Oncology 18(4): 759-765
Saranath, D.; Khan, Z.; Tandle, A.T.; Dedhia, P.; Sharma, B.; Contractor, R.; Shrivastava, S.; Dinshaw, K. 2002: HPV16/18 prevalence in cervical lesions/cancers and p53 genotypes in cervical cancer patients from India. Gynecologic Oncology 86(2): 157-162
Zhang, L.F.; Zhou, J.; Chen, S.; Cai, L.L.; Bao, Q.Y.; Zheng, F.Y.; Lu, J.Q.; Padmanabha, J.; Hengst, K.; Malcolm, K.; Frazer, I.H. 2000: HPV6b virus like particles are potent immunogens without adjuvant in man. Vaccine 18(11-12): 1051-1058
Hanson, K.G.; Steinhauer, K.; Reizer, J.; Hillen, W.; Stülke, Jörg. 2002: HPr kinase/phosphatase of Bacillus subtilis: expression of the gene and effects of mutations on enzyme activity, growth and carbon catabolite repression. Microbiology 148(Pt 6): 1805-1811
Incandela, L.; Belcaro, G.; Renton, S.; DeSanctis, M.T.; Cesarone, M.R.; Bavera, P.; Ippolito, E.; Bucci, M.; Griffin, M.; Geroulakos, G.; Dugall, M.; Golden, G.; Acerbi, G. 2002: HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial. Journal of Cardiovascular Pharmacology and Therapeutics 7(Suppl): S7
Vega, A.; Barros, F.; Lleonart, M.E.; Ramon y Cajal, S.; Carracedo, A. 2001: HRAS1 minisatellite alleles in colorectal carcinoma: relationship to microsatelite instability. Anticancer Research 21(4a): 2855-2860
Firgaira, F.A.; Seshadri, R.; McEvoy, C.R.; Dite, G.S.; Giles, G.G.; McCredie, M.R.; Southey, M.C.; Venter, D.J.; Hopper, J.L. 1999: HRAS1 rare minisatellite alleles and breast cancer in Australian women under age forty years. Journal of the National Cancer Institute 91(24): 2107-2111
Suk, J.Y.; Kim, Y.S.; Park, W.J. 1999: HRC (histidine-rich Ca2+ binding protein) resides in the lumen of sarcoplasmic reticulum as a multimer. Biochemical and Biophysical Research Communications 263(3): 667-671
Wilhovsky, S.; Gardner, R.; Hampton, R. 2000: HRD gene dependence of endoplasmic reticulum-associated degradation. Molecular Biology of the Cell 11(5): 1697-1708
Bays, N.W.; Wilhovsky, S.K.; Goradia, A.; Hodgkiss-Harlow, K.; Hampton, R.Y. 2001: HRD4/NPL4 is required for the proteasomal processing of ubiquitinated ER proteins. Molecular Biology of the Cell 12(12): 4114-4128
Rousselot-Pailley, P.; Boutillon, C.; Wieruszeski, J-Michel.; Lippens, G. 2003: HRMAS NMR observation of beta-sheet secondary structure on a water swollen solid support. Journal of Peptide Science: An Official Publication of the European Peptide Society 9(1): 47-53
Fournier, B.; Rovira, C.; Mailly, P.; Fuhrman, Y.; Mariani, J. 2002: HRP injection in lobule VI-VIi of the cerebellar cortex reveals a bilateral inferior olive projection in granuloprival rats. Journal of Comparative Neurology 449(1): 65-75
Shan, D.; Cosnier, S.; Mousty, C. 2003: HRP wiring by redox active layered double hydroxides: Application to the mediated H2O2 detection. Analytical Letters 36(5): 909-922
Alonso Lomillo, M.A.; Kauffmann, J.M.; Arcos Martinez, M.J. 2003: HRP-based biosensor for monitoring rifampicin. Biosensors and Bioelectronics 18(9): 1165-1171
Howell, V.M.; Haven, C.J.; Kahnoski, K.; Khoo, S.K.; Petillo, D.; Chen, J.; Fleuren, G.J.; Robinson, B.G.; Delbridge, L.W.; Philips, J.; Nelson, A.E.; Krause, U.; Hammje, K.; Dralle, H.; Hoang-Vu, C.; Gimm, O.; Marsh, D.J.; Morreau, H.; Teh, B.T. 2003: HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. Journal of Medical Genetics 40(9): 657-663
Schneider, H.P.G. 1999: HRT and cancer risk: Separating fact from fiction. Maturitas 33(Suppl 1): S65-S72
Schneider, Hermann, P.G. 2002: HRT and cancer risks. Maturitas 43(Suppl 1): S35-S52
Compton, J.; Van Amelsvoort, T.; Murphy, D. 2001: HRT and its effect on normal ageing of the brain and dementia. British Journal of Clinical Pharmacology 52(6): 647-653
Manning, P.J.; Sutherland, W.H.F.; Allum, A.R.; de Jong, S.A.; Jones, S.D. 2003: HRT does not improve urinary albumin excretion in postmenopausal diabetic women. Diabetes Research and Clinical Practice 60(1): 33-39
Sismondi, P.; Biglia, N.; Giai, M.; Ponzone, R.; Roagna, R.; Sgro, L.; Campagnoli, C. 1999: HRT, breast and endometrial cancers: Strategies and intervention options. Maturitas 32(3): 131-139
Wang, W.; Prince, C.Z.; Hu, X.; Pollman, M.J. 2003: HRT1 modulates vascular smooth muscle cell proliferation and apoptosis. Biochemical and Biophysical Research Communications 308(3): 596-601
Song Anqi; Niu Xiaolin; Zhang Chaoying 1999: HRV changes of early repolarization syndrome. Xi'an Yike Daxue Xuebao 20(1): 81-83
Chang, M.S.; Sasaki, H.; Campbell, M.S.; Kraeft, S.K.; Sutherland, R.; Yang, C.Y.; Liu, Y.; Auclair, D.; Hao, L.; Sonoda, H.; Ferland, L.H.; Chen, L.B. 1999: HRad17 colocalizes with NHP2L1 in the nucleolus and redistributes after UV irradiation. Journal of Biological Chemistry 274(51): 36544-36549
Bao, S.; Chang, M.S.; Auclair, D.; Sun, Y.; Wang, Y.; Wong, W.K.; Zhang, J.; Liu, Y.; Qian, X.; Sutherland, R.; Magi-Galluzi, C.; Weisberg, E.; Cheng, E.Y.; Hao, L.; Sasaki, H.; Campbell, M.S.; Kraeft, S.K.; Loda, M.; Lo, K.M.; Chen, L.B. 1999: HRad17, a human homologue of the Schizosaccharomyces pombe checkpoint gene rad17, is overexpressed in colon carcinoma. Cancer Research 59(9): 2023-2028
Ingley, E.; Sarna, M.K.; Beaumont, J.G.; Tilbrook, P.A.; Tsai, S.; Takemoto, Y.; Williams, J.H.; Klinken, S.P. 2000: HS1 interacts with Lyn and is critical for erythropoietin-induced differentiation of erythroid cells. Journal of Biological Chemistry 275(11): 7887-7893
Wai, A.W.K.; Gillemans, N.; Raguz-Bolognesi, S.; Pruzina, S.; Zafarana, G.; Meijer, D.; Philipsen, S.; Grosveld, F. 2003: HS5 of the human beta-globin locus control region: a developmental stage-specific border in erythroid cells. EMBO Journal 22(17): 4489-4500
Chowdhary, B.P.; Raudsepp, T. 2000: HSA4 and GGA4: remarkable conservation despite 300-Myr divergence. Genomics 64(1): 102-105
Gambacorta, A.; Farah, M.E.; Tofani, D. 1999: HSAB driven chemoselectivity in alkylation of uracil derivatives. A high yielding preparation of 3-alkylated and unsymmetrically 1,3-dialkylated uracils. Tetrahedron 55(43): 12615-12628
Wu, A.H.; Seow, A.; Arakawa, K.; Van Den Berg, D.; Lee, H.-P.; Yu, M.C. 2003: HSD17B1 and CYP17 polymorphisms and breast cancer risk among Chinese women in Singapore. International Journal of Cancer 104(4): 450-457
Grably, M.R.; Stanhill, A.; Tell, O.; Engelberg, D. 2002: HSF and Msn2/4p can exclusively or cooperatively activate the yeast HSP104 gene. Molecular Microbiology 44(1): 21-35
Hu, Y.; Mivechi, N.F. 2003: HSF-1 interacts with Ral-binding protein 1 in a stress-responsive, multiprotein complex with HSP90 in vivo. Journal of Biological Chemistry 278(19): 17299-17306
Ianaro, A.; Ialenti, A.; Maffia, P.; Pisano, B.; Di Rosa, M. 2001: HSF1/hsp72 pathway as an endogenous anti-inflammatory system. FEBS Letters 499(3): 239-244
Oda, T.; Muramatsu, M.A.; Isogai, T.; Masuho, Y.; Asano, S.; Yamashita, T. 2001: HSH2: a novel SH2 domain-containing adapter protein involved in tyrosine kinase signaling in hematopoietic cells. Biochemical and Biophysical Research Communications 288(5): 1078-1086
Kato, S.; Matsuyama, T.; Serizawa, T.; Kishida, A.; Akashi, M. 2001: HSP 47 and collagen mRNA expression in L929 cells adhered to lipid films. Journal of Biomaterials Science. Polymer Edition 12(2): 149-156
Fehrenbach, E.; Passek, F.; Niess, A.M.; Pohla, H.; Weinstock, C.; Dickhuth, H.H.; Northoff, H. 2000: HSP expression in human leukocytes is modulated by endurance exercise. Medicine and Science in Sports and Exercise 32(3): 592-600
Bidmon, B.; Endemann, M.; Müller, T.; Arbeiter, K.; Herkner, K.; Aufricht, C. 2002: HSP-25 and HSP-90 stabilize Na,K-ATPase in cytoskeletal fractions of ischemic rat renal cortex. Kidney International 62(5): 1620-1627
Imbriano, C.; Bolognese, F.; Gurtner, A.; Piaggio, G.; Mantovani, R. 2001: HSP-CBF is an NF-Y-dependent coactivator of the heat shock promoters CCAAT boxes. Journal of Biological Chemistry 276(28): 26332-26339
Uchio, E.; Stanford, M.; Hasan, A.; Satoh, S.; Ohno, S.; Shinnick, T.; van der Zee, R.; Mizushima, Y.; Lehner, T. 1998: HSP-derived peptides inducing uveitis and IgG and IgA antibodies. Experimental Eye Research 67(6): 719-727
Zara, S.; Antonio Farris, G.; Budroni, M.; Bakalinsky, A.T. 2002: HSP12 is essential for biofilm formation by a Sardinian wine strain of S. cerevisiae. Yeast 19(3): 269-276
Lee, S.; Owen, H.A.; Prochaska, D.J.; Barnum, S.R. 2000: HSP16.6 is involved in the development of thermotolerance and thylakoid stability in the unicellular cyanobacterium, Synechocystis sp. PCC 6803. Current Microbiology 40(4): 283-287
Kozawa, O.; Matsuno, H.; Niwa, M.; Hatakeyama, D.; Oiso, Y.; Kato, K.; Uematsu, T. 2002: HSP20, low-molecular-weight heat shock-related protein, acts extracellularly as a regulator of platelet functions: A novel defense mechanism. Life Sciences 72(2): 113-124
Benndorf, R.; Sun, X.; Gilmont, R.R.; Biederman, K.J.; Molloy, M.P.; Goodmurphy, C.W.; Cheng, H.; Andrews, P.C.; Welsh, M.J. 2001: HSP22, a new member of the small heat shock protein superfamily, interacts with mimic of phosphorylated HSP27 ((3D)HSP27). Journal of Biological Chemistry 276(29): 26753-26761
Schäfer, C.; Clapp, P.; Welsh, M.J.; Benndorf, R.; Williams, J.A. 1999: HSP27 expression regulates CCK-induced changes of the actin cytoskeleton in CHO-CCK-A cells. American Journal of Physiology 277(6): C1032-C1043
Garrido, C.; Bruey, J.M.; Fromentin, A.; Hammann, A.; Arrigo, A.P.; Solary, E. 1999: HSP27 inhibits cytochrome c-dependent activation of procaspase-9. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 13(14): 2061-2070
Parcellier, A.; Schmitt, E.; Gurbuxani, S.; Seigneurin-Berny, Dé.; Pance, A.; Chantôme, Aélie.; Plenchette, Séphanie.; Khochbin, S.; Solary, E.; Garrido, C. 2003: HSP27 is a ubiquitin-binding protein involved in I-kappa Balpha proteasomal degradation. Molecular and Cellular Biology 23(16): 5790-5802
Lambert, H.; Charette, S.J.; Bernier, A.F.; Guimond, A.; Landry, J. 1999: HSP27 multimerization mediated by phosphorylation-sensitive intermolecular interactions at the amino terminus. Journal of Biological Chemistry 274(14): 9378-9385
Hernández, M.P.; Chadli, A.; Toft, D.O. 2002: HSP40 binding is the first step in the HSP90 chaperoning pathway for the progesterone receptor. Journal of Biological Chemistry 277(14): 11873-11881
Macdonald, J.R.; Bächinger, H.P. 2001: HSP47 binds cooperatively to triple helical type i collagen but has little effect on the thermal stability or rate of refolding. Journal of Biological Chemistry 276(27): 25399-25403
Rocnik, E.; Saward, L.; Pickering, J.G. 2001: HSP47 expression by smooth muscle cells is increased during arterial development and lesion formation and is inhibited by fibrillar collagen. Arteriosclerosis Thrombosis and Vascular Biology 21(1): 40-46
Shastry, S.; Toft, D.O.; Joyner, M.J. 2002: HSP70 and HSP90 expression in leucocytes after exercise in moderately trained humans. Acta Physiologica Scandinavica 175(2): 139-146
Gotohda, T.; Kubo, S.; Kitamura, O.; Tokunaga, I.; Eguchi, A.; Orihara, Y.; Tsuda, R.; Ikematsu, K.; Nakasono, I. 2000: HSP70 and c-Fos expression of brain stem hypoglossal nucleus in drowning. Journal of Medical Investigation: Jmi 47(1-2): 76-79
Okada, S.; Okada, T.; Aimi, T.; Morinaga, T.; Itoh, T. 2000: HSP70 and ribosomal protein L2: Novel 5S rRNA binding proteins in Escherichia coli. FEBS Letters 485(2-3): 153-156
Vabulas, R.M.; Ahmad-Nejad, P.; Ghose, S.; Kirschning, C.J.; Issels, R.D.; Wagner, H. 2002: HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. Journal of Biological Chemistry 277(17): 15107-15112
Bodega, G.; Hernández, C.; Suárez, I.; Martín, M.; Fernández, Bín. 2002: HSP70 constitutive expression in rat central nervous system from postnatal development to maturity. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 50(9): 1161-1168
Weingartmann, G.; Oehler, R.; Derkits, S.; Oismüller, C.; Függer, R.; Roth, E. 1999: HSP70 expression in granulocytes and lymphocytes of patients with polytrauma: comparison with plasma glutamine. Clinical Nutrition 18(2): 121-124
Bitting, L.; Watson, F.L.; O'Hara, B.F.; Kilduff, T.S.; Heller, H.C. 1999: HSP70 expression is increased during the day in a diurnal animal, the golden-mantled ground squirrel Spermophilus lateralis. Molecular and Cellular Biochemistry 199(1-2): 25-34
Leitão, A.A.; Leite, C.A.; Santos, B.C.; Boim, M.A. 2003: HSP70 induced by hyperosmotic stress partially protects LLC-PK1 cells against nephrotoxic drugs. Nephron. Experimental Nephrology 94(3): E94-102
Andrés, D.; Alvarez, A.M.; Díez-Fernández, C.; Zaragoza, A.; Cascales, M. 2000: HSP70 induction by cyclosporine A in cultured rat hepatocytes: Effect of vitamin E succinate. Journal of Hepatology 33(4): 570-579
Calabrese, V.; Testa, G.; Ravagna, A.; Bates, T.E.; Stella, A.M. 2000: HSP70 induction in the brain following ethanol administration in the rat: regulation by glutathione redox state. Biochemical and Biophysical Research Communications 269(2): 397-400
Minois, N.; Guinaudy, M.J.; Payre, F.; Le Bourg, E. 1999: HSP70 induction may explain the long-lasting resistance to heat of Drosophila melanogaster having lived in hypergravity. Mechanisms of Ageing and Development 109(1): 65-77
Glowala, M.; Mazurek, A.; Piddubnyak, V.; Fiszer-Kierzkowska, A.; Michalska, J.; Krawczyk, Z. 2002: HSP70 overexpression increases resistance of V79 cells to cytotoxicity of airborne pollutants, but does not protect the mitotic spindle against damage caused by airborne toxins. Toxicology 170(3): 211-219
Van Molle, W.; Wielockx, B.; Mahieu, T.; Takada, M.; Taniguchi, T.; Sekikawa, K.; Libert, C. 2002: HSP70 protects against TNF-induced lethal inflammatory shock. Immunity 16(5): 685-695
Van Nieuwenhoven, F.A.; Martin, X.; Heijnen, V.V.; Cornelussen, R.N.; Snoeckx, L.H. 2001: HSP70-mediated acceleration of translational recovery after stress is independent of ribosomal RNA synthesis. European Journal of Cell Biology 80(9): 586-592
Smolka, M.B.; Zoppi, C.C.; Alves, A.A.; Silveira, L.R.; Marangoni, S.; Pereira-Da-Silva, L.; Novello, J.C.; Macedo, D.V. 2000: HSP72 as a complementary protection against oxidative stress induced by exercise in the soleus muscle of rats. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 279(5): R1539-R1545
Febbraio, M.A.; Koukoulas, I. 2000: HSP72 gene expression progressively increases in human skeletal muscle during prolonged, exhaustive exercise. Journal of Applied Physiology 89(3): 1055-1060
Zhao Jun; Yang Shou Jing; Liu Yan Fang 2001: HSP72-like immunoreactivities in the brains of mice experimentally infected with Hantavirus. Virologica Sinica 16(1): 11-14
Bishop, C.D.; Bates, W.R.; Brandhorst, B.P. 2002: HSP90 function is required for morphogenesis in ascidian and echinoid embryos. Development Genes and Evolution 212(2): 70-80
McDowell, T.S.; Yukhananov, R.Y. 2002: HSP90 inhibitors alter capsaicin- and ATP-induced currents in rat dorsal root ganglion neurons. Neuroreport 13(4): 437-441
Nakamura, T.; Hinagata, J.-i.; Tanaka, T.; Imanishi, T.; Wada, Y.; Kodama, T.; Doi, T. 2002: HSP90, HSP70, and GAPDH directly interact with the cytoplasmic domain of macrophage scavenger receptors. Biochemical and Biophysical Research Communications 290(2): 858-864
Dugyala, R.R.; Claggett, T.W.; Kimmel, G.L.; Kimmel, C.A. 2002: HSP90alpha, HSP90beta, and p53 expression following in vitro hyperthermia exposure in gestation day 10 rat embryos. Toxicological Sciences: An Official Journal of the Society of Toxicology 69(1): 183-190
Giráldez, A.J.; Copley, R.R.; Cohen, S.M. 2002: HSPG modification by the secreted enzyme Notum shapes the Wingless morphogen gradient. Developmental Cell 2(5): 667-676
Harvey, B.K.; Chang, C.F.; Chiang, Y.H.; Bowers, W.J.; Morales, M.; Hoffer, B.J.; Wang, Y.; Federoff, H.J. 2003: HSV amplicon delivery of glial cell line-derived neurotrophic factor is neuroprotective against ischemic injury. Experimental Neurology 183(1): 47-55
Garweg, J.G.; Russ, C.E.; Schellhorn, M.; Böhnke, M.; Halberstadt, M. 2003: HSV-1 antigens and DNA in the corneal explant buttons of patients with non-herpetic or clinically atypical herpetic stromal keratitis. Graefe's Archive for Clinical and Experimental Ophthalmology 241(9): 734-739
Zheng, X.; Marquart, M.E.; Loustch, J.M.; Shah, P.; Sainz, B.; Ray, A.; O'Callaghan, R.J.; Kaufman, H.E.; Hill, J.M. 1999: HSV-1 migration in latently infected and naive rabbits after penetrating keratoplasty. IOVS Investigative Ophthalmology and Visual Science 40(11): 2490-2497
Fischer, N.O.; Mbuy, G.N.; Woodruff, R.I. 2001: HSV-2 disrupts gap junctional intercellular communication between mammalian cells in vitro. Journal of Virological Methods 91(2): 157-166
Viter, S.; Shaw, K.J.; Gennaro, M.L. 1999: HSa of Staphylococcus aureus, a new member of the HU family of bacterial histone-like proteins. Research in Microbiology 150(4): 287-290
Pontier, C.; Pachot, J.; Botham, R.; Lenfant, B.; Arnaud, P. 2001: HT29-MTX and Caco-2/TC7 monolayers as predictive models for human intestinal absorption: role of the mucus layer. Journal of Pharmaceutical Sciences 90(10): 1608-1619
Loganzo, F.; Discafani, C.M.; Annable, T.; Beyer, C.; Musto, S.; Hari, M.; Tan, X.; Hardy, C.; Hernandez, R.; Baxter, M.; Singanallore, T.; Khafizova, G.; Poruchynsky, M.S.; Fojo, T.; Nieman, J.A.; Ayral-Kaloustian, S.; Zask, A.; Andersen, R.J.; Greenberger, L.M. 2003: HTI-286, a synthetic analogue of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo. Cancer Research 63(8): 1838-1845
Dobbs, L.G.; Gonzalez, R.F.; Allen, L.; Froh, D.K. 1999: HTI56, an integral membrane protein specific to human alveolar type i cells. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 47(2): 129-137
Romeo, M.J.; Angus-Hill, M.L.; Sobering, A.K.; Kamada, Y.; Cairns, B.R.; Levin, D.E. 2002: HTL1 encodes a novel factor that interacts with the RSC chromatin remodeling complex in Saccharomyces cerevisiae. Molecular and Cellular Biology 22(23): 8165-8174
Anonymous 2001: HTLV European Research Network Meeting, Potsdam, Germany, May 19-21, 2000. Virus Research 78(1-2): 108-129
Gamba, J.C.; Muscatello, A.V.; Jimenez, S.R. 1998: HTLV I and II infections in blood banks. Prensa Medica Argentina 85(9): 1040-1042
Yoshida, M.; Suzuki, T. 2000: HTLV type 1 Tax oncoprotein binds to DNA topoisomerase I and inhibits its catalytic activity. Aids Research and Human Retroviruses 16(16): 1639-1645
Wrzesinski, S.; Séguin, R.; Liu, Y.; Domville, S.; Planelles, V.; Massa, P.; Barker, E.; Antel, J.; Feuer, G. 2000: HTLV type 1 Tax transduction in microglial cells and astrocytes by lentiviral vectors. Aids Research and Human Retroviruses 16(16): 1771-1776
Sagara, Y.; Inoue, Y.; Kojima, E.; Shiraki, H.; Maeda, Y. 2000: HTLV type 1 envelope glycoprotein gp46 evokes necrosis by binding to receptor complex. Aids Research and Human Retroviruses 16(16): 1701-1704
Kazanji, M. 2000: HTLV type 1 infection in squirrel monkeys (Saimiri sciureus): a promising animal model for HTLV type 1 human infection. Aids Research and Human Retroviruses 16(16): 1741-1746
Peters, A.A.; Coulthart, M.B.; Oger, J.J.; Waters, D.J.; Crandall, K.A.; Baumgartner, A.A.; Ward, R.H.; Dekaban, G.A. 2000: HTLV type I/Ii in British Columbia Amerindians: a seroprevalence study and sequence characterization of an HTLV type IIa isolate. Aids Research and Human Retroviruses 16(9): 883-892
Cabre, P.; Smadja, D.; Cabié, A.; Newton, C.R. 2000: HTLV-1 and HIV infections of the central nervous system in tropical areas. Journal of Neurology Neurosurgery and Psychiatry 68(5): 550-557
Etzel, A.; Shibata, G.Y.; Rozman, M.; Jorge, M.L.; Damas, C.D.; Segurado, A.A. 2001: HTLV-1 and HTLV-2 infections in HIV-infected individuals from Santos, Brazil: seroprevalence and risk factors. Journal of Acquired Immune Deficiency Syndromes 26(2): 185-190
Hasui, K. 1999: HTLV-1 and gastrointestinal tract lesions. Stomach and Intestine 34(7): 873-881
Gilbert, D.T.; Morgan, O.; Smikle, M.F.; Simeon, D.; Barton, E.N. 2001: HTLV-1 associated polymyositis in Jamaica. Acta Neurologica Scandinavica 104(2): 101-104
Liang, W.; Hague, B.; Zhao, T.; Kindt, T.J. 2001: HTLV-1 cell lines differ in constitutively activated signaling pathways that can be altered by cytokine exposure. Virology 290(1): 91-98
Bangham, C.R. 2000: HTLV-1 infections. Journal of Clinical Pathology 53(8): 581-586
Nicot, C.; Mulloy, J.C.; Ferrari, M.G.; Johnson, J.M.; Fu, K.; Fukumoto, R.; Trovato, R.; Fullen, J.; Leonard, W.J.; Franchini, G. 2001: HTLV-1 p12(I) protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cells. Blood 98(3): 823-829
Okazaki, S.; Moriuchi, R.; Yosizuka, N.; Sugahara, K.; Maeda, T.; Jinnai, I.; Tomonaga, M.; Kamihira, S.; Katamine, S. 2001: HTLV-1 proviruses encoding non-functional TAX in adult T-cell leukemia. Virus Genes 23(2): 123-135
Le Blanc, I.; Grange, M.P.; Delamarre, L.; Rosenberg, A.R.; Blot, V.; Pique, C.; Dokhélar, M.C. 2001: HTLV-1 structural proteins. Virus Research 78(1-2): 5-16
Nakase, K.; Hasegawa, M.; Tsuji, K.; Ikeda, T.; Tamaki, S.; Tanigawa, M.; Miyanishi, E.; Shiku, H. 2000: HTLV-1 unrelated adult T-cell leukemia/lymphoma with unique phenotype and karyotype. American Journal of Hematology 64(1): 64-66
Machigashira, N.; Yoshida, Y.; Wang, S.; Osame, M. 2001: HTLV-1-associated myelopathy/tropical spastic paraparesis with pseudohypoparathyroidism. Neurology 56(1): 104-106
Hida, A.; Kawabe, Y.; Kawakami, A.; Migita, K.; Tominaga, M.; Nakamura, H.; Eguchi, K. 1999: HTLV-I associated Sjögren's syndrome is aetiologically distinct from anti-centromere antibodies positive Sjögren's syndrome. Annals of the Rheumatic Diseases 58(5): 320-322
Fritzen, R.; Dressel, A. 2001: HTLV-i associated myelopathy/tropical spastic paraparesis with pseudohypothyroidism. Neurology 57(7): 1349-1350
Dourado, I.; Andrade, T.; Galvão-Castro, B. 1998: HTLV-I in Northeast Brazil: differences for male and female injecting drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 19(4): 426-429
Gurtsevich, V.E. 2000: HTLV-I infection in Russia and CIS (seroepidemiological and molecular-biological investigations). Gematologiya i Transfuziologiya 45(3): 56-60
Ha, J.J.; Gaul, D.A.; Mariani, V.L.; Ding, Y.S.; Ikeda, R.A.; Shuker, S.B. 2002: HTLV-i protease cleavage of P19/24 substrates is not dependent on NaCl concentration. Bioorganic Chemistry 30(2): 138-144
Matsuzaki, T.; Nakagawa, M.; Nagai, M.; Usuku, K.; Higuchi, I.; Arimura, K.; Kubota, H.; Izumo, S.; Akiba, S.; Osame, M. 2001: HTLV-I proviral load correlates with progression of motor disability in HAM/TSP: analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years. Journal of Neurovirology 7(3): 228-234
Kubota, R.; Kawanishi, T.; Matsubara, H.; Manns, A.; Jacobson, S. 2000: HTLV-i specific IFN-gamma+ CD8+ lymphocytes correlate with the proviral load in peripheral blood of infected individuals. Journal of Neuroimmunology 102(2): 208-215
Fujino, T.; Nagata, Y. 2000: HTLV-I transmission from mother to child. Journal of Reproductive Immunology 47(2): 197-206
Nakatsuji, Y.; Sugai, F.; Watanabe, S.; Kaido, M.; Koguchi, K.; Abe, K.; Sakoda, S. 2000: HTLV-I-associated myelopathy manifested after renal transplantation. Journal of the Neurological Sciences 177(2): 154-156
Shakudo, M.; Inoue, Y.; Tsutada, T. 1999: HTLV-I-associated myelopathy: acute progression and atypical MR findings. Ajnr. American Journal of Neuroradiology 20(8): 1417-1421
Regner, A.; Bianchini, O.; Jardim, C.; Menna-Barreto, M. 2002: HTLV-I-associated myelopathy: are ferritin, S100beta protein, or guanine nucleotides CSF markers of disease?. Journal of Neurovirology 8(1): 64-67
Smith, D.; Buckle, G.J.; Hafler, D.A.; Frank, D.A.; Höllsberg, P. 1999: HTLV-I-infected T cells evade the antiproliferative action of IFN-beta. Virology 257(2): 314-321
Tosswill, J.H.; Taylor, G.P.; Tedder, R.S.; Mortimer, P.P. 2000: HTLV-I/II associated disease in England and Wales, 1993-7: retrospective review of serology requests. Bmj 320(7235): 611-612
Soldan, S.S.; Graf, M.D.; Waziri, A.; Flerlage, A.N.; Robinson, S.M.; Kawanishi, T.; Leist, T.P.; Lehky, T.J.; Levin, M.C.; Jacobson, S. 1999: HTLV-I/Ii seroindeterminate Western blot reactivity in a cohort of patients with neurological disease. Journal of Infectious Diseases 180(3): 685-694
Safaeian, M.; Wilson, L.E.; Taylor, E.; Thomas, D.L.; Vlahov, D. 2000: HTLV-II and bacterial infections among injection drug users. Journal of Acquired Immune Deficiency Syndromes 24(5): 483-487
Casoli, C.; Vicenzi, E.; Cimarelli, A.; Magnani, G.; Ciancianaini, P.; Cattaneo, E.; Dall'Aglio, P.; Poli, G.; Bertazzoni, U. 2000: HTLV-II down-regulates HIV-1 replication in IL-2-stimulated primary PBMC of coinfected individuals through expression of MIP-1alpha. Blood 95(9): 2760-2769
Silva, E.A.; Otsuki, K.; Leite, A.Claudia.B.; Alamy, A.H.; Sá-Carvalho, D.; Vicente, A.Carolina.P. 2002: HTLV-II infection associated with a chronic neurodegenerative disease: Clinical and molecular analysis. Journal of Medical Virology 66(2): 253-257
Bedewy, K., M.L.; Ibrahim, Y., N.; Aziz, H., A.S.Abdel 2001: HTLV1/2 infection among renal dialysis patients in Egypt. Journal of the Medical Research Institute 22(2): 105-114
Edwards, B.S.; Kuckuck, F.W.; Prossnitz, E.R.; Ransom, J.T.; Sklar, L.A. 2001: HTPS flow cytometry: a novel platform for automated high throughput drug discovery and characterization. Journal of Biomolecular Screening 6(2): 83-90
Lappalainen, J.; Long, J.C.; Virkkunen, M.; Ozaki, N.; Goldman, D.; Linnoila, M. 1999: HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM-III-R psychiatric diagnoses. Biological Psychiatry 46(6): 821-826
Landro, J.A.; Taylor, I.C.A.; Stirtan, W.G.; Osterman, D.G.; Kristie, J.; Hunnicutt, E.J.; Rae, P.M.M.; Sweetnam, P.M. 2000: HTS in the new millennium: The role of pharmacology and flexibility. Journal of Pharmacological and Toxicological Methods 44(1): 273-289
Wojtuszewski, K.; Mukerji, I. 2003: HU binding to bent DNA: a fluorescence resonance energy transfer and anisotropy study. Biochemistry 42(10): 3096-3104
Hashimoto, M.; Imhoff, B.; Ali, M.M.; Kow, Y.W. 2003: HU protein of Escherichia coli has a role in the repair of closely opposed lesions in DNA. Journal of Biological Chemistry 278(31): 28501-28507
Gühring, H.; Schuster, J.; Hamza, M.; Ates, M.; Kotalla, C.E.; Brune, K. 2001: HU-210 shows higher efficacy and potency than morphine after intrathecal administration in the mouse formalin test. European Journal of Pharmacology 429(1-3): 127-134
Wery, M.; Woldringh, C.L.; Rouviere-Yaniv, J. 2001: HU-GFP and DAPI co-localize on the Escherichia coli nucleoid. Biochimie 83(2): 193-200
Dame, R.Thei.; Goosen, N. 2002: HU: Promoting or counteracting DNA compaction?. FEBS Letters 529(2-3): 151-156
Western, T.L.; Cheng, Y.; Liu, J.; Chen, X. 2002: HUA ENHANCER2, a putative DExH-box RNA helicase, maintains homeotic B and C gene expression in Arabidopsis. Development 129(7): 1569-1581
Itoh, M.; Watanabe, M.; Yamada, Y.; Furukawa, K.; Taniguchi, M.; Hata, T.; Schmitt, M.; Ikeda, H.; Yamaguchi, M.; Ohno, T.; Nakashima, K.; Shiku, H. 1999: HUB1 is an autoantigen frequently eliciting humoral immune response in patients with adult T cell leukemia. International Journal of Oncology 14(4): 703-708
Pawłowski, R. 1999: HUMFIBRA allele distribution in northern Poland using capillary electrophoresis. International Journal of Legal Medicine 112(2): 139-141
Fenech, M.; Chang, W.P.; Kirsch Volders, M.; Holland, N.; Bonassi, S.; Zeiger, E. 2003: HUMN project: Detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. Mutation Research 534(1-2): 65-75, 10 January
Trachtman, H.; Kaplan, B.S. 2001: HUS or not HUS?. Pediatric Nephrology 16(8): 686
Brink, A.; Huff, H.P.; Goehlich, F. 2000: HUSAR: A new herbicide for control of Apera spica-venti (L.) BEAUV, Poa spp. and broad leaf weeds in cereals. Zeitschrift fuer Pflanzenkrankheiten und Pflanzenschutz (Special Iss.17): 555-564
Langeggen, H.; Namork, E.; Johnson, E.; Hetland, G. 2003: HUVEC take up opsonized zymosan particles and secrete cytokines IL-6 and IL-8 in vitro. FEMS Immunology and Medical Microbiology 36(1-2): 55-61
Bonassi, S.; Fenech, M.; Lando, C.; Lin, Y.P.; Ceppi, M.; Chang, W.P.; Holland, N.; Kirsch-Volders, M.; Zeiger, E.; Ban, S.; Barale, R.; Bigatti, M.P.; Bolognesi, C.; Jia, C.; Di Giorgio, M.; Ferguson, L.R.; Fucic, A.; Lima, O.G.; Hrelia, P.; Krishnaja, A.P.; Lee, T.K.; Migliore, L.; Mikhalevich, L.; Mirkova, E.; Mosesso, P.; Müller, W.U.; Odagiri, Y.; Scarffi, M.R.; Szabova, E.; Vorobtsova, I.; Vral, A.; Zijno, A. 2001: HUman Micro Nucleus Project: International database comparison for results with the cytokinesis-block micronucleus assay in human lymphocytes: I. Effect of laboratory protocol, scoring criteria, and host factors on the frequency of micronuclei. Environmental and Molecular Mutagenesis 37(1): 31-45
Budowle, B.; Allard, M.W.; Fisher, C.L.; Isenberg, A.R.; Monson, K.L.; Stewart, J.E.B.; Wilson, M.R.; Miller, K.W.P. 2002: HVi and HVIi mitochondrial DNA data in Apaches and Navajos. International Journal of Legal Medicine 116(4): 212-215
Ferrari, M.G.; Rivadeneira, E.D.; Jarrett, R.; Stevceva, L.; Takemoto, S.; Markham, P.; Franchini, G. 2001: HV(MNE), a novel lymphocryptovirus related to Epstein-Barr virus, induces lymphoma in New Zealand White rabbits. Blood 98(7): 2193-2199
Verwaal, R.é; Paalman, J.W.G.; Hogenkamp, A.; Verkleij, A.J.; Verrips, C.T.; Boonstra, J. 2002: HXT5 expression is determined by growth rates in Saccharomyces cerevisiae. Yeast 19(12): 1029-1038
James, E.; Scott, D.; Chai, J.-G.; Millrain, M.; Chandler, P.; Simpson, E. 2002: HY peptides modulate transplantation responses to skin allografts. International Immunology 14(11): 1333-1342
García de la Torre, J.; Llorca, O.; Carrascosa, J.L.; Valpuesta, J.M. 2001: HYDROMIC: Prediction of hydrodynamic properties of rigid macromolecular structures obtained from electron microscopy images. European Biophysics Journal: Ebj 30(6): 457-462
Bader, L.; Blumenstock, G.; Birkner, B.; Leiss, O.; Heesemann, J.; Riemann, J.F.; Selbmann, H.K. 2002: HYGEA (Hygiene in der Gastroenterologie - Endoskop-Aufbereitung): Studie zur Qualitaet der Aufbereitung von flexiblen Endoskopen in Klinik und Praxis. Zeitschrift fuer Gastroenterologie 40(3): 157-170
Callebaut, I.; Gilgès, D.; Vigon, I.; Mornon, J.P. 2000: HYR, an extracellular module involved in cellular adhesion and related to the immunoglobulin-like fold. Protein Science: a Publication of the Protein Society 9(7): 1382-1390
Ge, H.; Chiesa, R.; Peña de Ortiz, S. 2003: HZF-3 expression in the amygdala after establishment of conditioned taste aversion. Neuroscience 120(1): 1-4
Starr, D.A.; Saffery, R.; Li, Z.; Simpson, A.E.; Choo, K.H.; Yen, T.J.; Goldberg, M.L. 2000: HZwint-1, a novel human kinetochore component that interacts with HZW10. Journal of Cell Science 113: 1939-1950
Hipler, U-C.; Fischer, T.W.; Elsner, P. 2003: HaCaT cell proliferation influenced by melatonin. Skin Pharmacology and Applied Skin Physiology 16(6): 379-385
Keller, G.; Ray, E.; Brown, P.O.; Winge, D.R. 2001: Haa1, a protein homologous to the copper-regulated transcription factor Ace1, is a novel transcriptional activator. Journal of Biological Chemistry 276(42): 38697-38702
Barton, R. 2000: Haast and the moa: Reversing the tyranny of distance. Pacific Science 54(3): 251-263
Sasidharan, N.; Rajesh, K.P.; Augustine, J. 1998: Habenaria periyarensis, a new orchid from India. Rheedea 8(2): 167-171
Miller, F.J.; Schlosser, P.M.; Janszen, D.B. 2000: Haber's rule: A special case in a family of curves relating concentration and duration of exposure to a fixed level of response for a given endpoint. Toxicology 149(1): 21-34
Ng, P., K.L.; Schubart, C., D. 2002: Haberma nanum, a new genus and new species of mangrove crab (Crustacea: Decapoda: Brachyura: Sesarmidae) from Singapore. Raffles Bulletin of Zoology 50(2): 437-442
Weickert, T.W.; Terrazas, A.; Bigelow, L.B.; Malley, J.D.; Hyde, T.; Egan, M.F.; Weinberger, D.R.; Goldberg, T.E. 2002: Habit and skill learning in schizophrenia: evidence of normal striatal processing with abnormal cortical input. Learning and Memory 9(6): 430-442
de Kinkelder, M.; Boelens, H. 1998: Habit-reversal treatment for children's stuttering: Assessment in three settings. Journal of Behavior Therapy and Experimental Psychiatry 29(3): 261-265
Heath, M.J.; Doyle, L.R.; Joshi, M.M.; Haberle, R.M. 1999: Habitability of planets around red dwarf stars. Origins of Life and Evolution of the Biosphere: the Journal of the International Society for the Study of the Origin of Life 29(4): 405-424
Whitmore, M.; Adolf, J.A.; Woolford, B.J. 2000: Habitability research priorities for the International Space Station and beyond. Aviation Space and Environmental Medicine 71(9 Suppl): A122-A125
Moser 2000: Habitat Conservation Plans under the U.S. endangered species act: The legal perspective. Environmental Management 26(S1): S7
Ellinger, N.; Hoedl, W. 2003: Habitat acoustics of a neotropical lowland rainforest. Bioacoustics 13(3): 297-321
Castro, K.M.; Cobb, J Stanley; Wahle, R.A.; Catena, J. 2001: Habitat addition and stock enhancement for American lobsters, Homarus americanus. ine and Freshwater Research 52(8): 1253-1261
Graham, A.K.; Buddle, C.M.; Spence, J.R. 2003: Habitat affinities of spiders living near a freshwater pond. Journal of Arachnology 31(1): 78-89
Biber, E. 2002: Habitat analysis of a rare dragonfly (Williamsonia lintneri) in Rhode Island. Northeastern Naturalist 9(3): 341-352
Bencini, R.; Mcculloch, C.; Mills, H., R.; Start, A., N. 2001: Habitat and diet of the dibbler (Parantechinus apicalis) on two islands in Jurien Bay, Western Australia. Wildlife Research 28(5): 465-468
Ledesma, M.E.; O'connor, N.J. 2001: Habitat and diet of the non-native crab Hemigrapsus sanguineus in southeastern New England. Northeastern Naturalist il 6; 8(1): 63-78
Ihl, C.; Klein, D.R. 2001: Habitat and diet selection by muskoxen and reindeer in western Alaska. Journal of Wildlife Management ober; 65(4): 964-972
Pavia, H.; Carr, H.; Aberg, P. 1999: Habitat and feeding preferences of crustacean mesoherbivores inhabiting the brown seaweed Ascophyllum nodosum (L.) Le Jol. and its epiphytic macroalgae. Journal of Experimental Marine Biology and Ecology 31 March; 2361: 15-32
Tew, K.S.; Han, C.C.; Chou, W.R.; Fang, L.S. 2002: Habitat and fish fauna structure in a subtropical mountain stream in Taiwan before and after a catastrophic typhoon. Environmental Biology of Fishes 65(4): 457-462
Castien, E.; Gosalbez, J. 1999: Habitat and food preferences in a guild of insectivorous mammals in the Western Pyrenees. Acta Theriologica 44(1): 1-13
Hook, T.O.; Eagan, N.M.; Webb, P.W. 2001: Habitat and human influences on larval fish assemblages in northern Lake Huron coastal marsh bays. Wetlands e; 21(2): 281-291
Doherty, P.F.Jr; Grubb, T.C.Jr 2000: Habitat and landscape correlates of presence, density, and species richness of birds wintering in forest fragments in Ohio. Wilson Bulletin 112(3): 388-394
Knights, B.C.; Vallazza, J.M.; Zigler, S.J.; Dewey, M.R. 2002: Habitat and movement of lake sturgeon in the upper Mississippi River system, USA. Transactions of the American Fisheries Society ; 131(3): 507-522
Yorio, P.; Rabano, D.E.; Friedrich, P. 2001: Habitat and nest site characteristics of Olrog's Gull Larus atlanticus breeding at Bahia San Blas, Argentina. Bird Conservation International 11(1): 27-34
Smith, R.N.; Anderson, S.H.; Cain, S.L.; Dunk, J.R. 2003: Habitat and nest-site use by Red-tailed Hawks in northwestern Wyoming. Journal of Raptor Research 37(3): 219-227
Bowles, D., E.; Barr, C., B.; Stanford, R. 2003: Habitat and phenology of the endangered riffle beetle Heterelmis comalensis and a coexisting species, Microcylloepus pusillus, (Coleoptera: Elmidae) at Comal Springs, Texas, USA. Archiv fur Hydrobiologie 156(3): 361-383
Trajano, E. 2001: Habitat and population data of troglobitic armored cave catfish, Ancistrus cryptophthalmus Reis, 1987, from central Brazil (Siluriformes: Loricariidae). Environmental Biology of Fishes 62(1-3): 195-200
Shadel, W.-Paul; Molofsky, J. 2002: Habitat and population effects on the germination and early survival of the invasive weed, Lythrum salicaria L. (purple loosestrife). Biological Invasions 4(4): 413-423
Radeloff, V.C.; Pidgeon, A.M.; Hostert, P. 1999: Habitat and population modelling of roe deer using an interactive geographic information system. Ecological Modelling 114(2-3): 287-304
Martinez Munoz, A.; Hewitt, D.; Valenzuela, S.; Uvalle, J.; Estrada, A.; Avendano, J.; Aranda, R. 2003: Habitat and population status of desert mule deer in Mexico. Zeitschrift fuer JagdwissenschaftMaerz; 49(1): 14-24
Watanabe, S.; Nakanishi, N.; Izawa, M. 2003: Habitat and prey resource overlap between the Iriomote cat Prionailurus iriomotensis and introduced feral cat Felis catus based on assessment of scat content and distribution. Mammal Study e; 28(1): 47-56
Oliver, D., L.; Chambers, M., A.; Parker, D., G. 2003: Habitat and resource selection of the painted honeyeater (Grantiella picta) on the northern floodplains region of New South Wales. Emu 103(2): 171-176
Streissl, F.; Hoedl, W. 2002: Habitat and shelter requirements of the stone crayfish, Austropotamobius torrentium Schrank. Hydrobiologia 1: 199
Ray, W.J.; Corkum, L.D. 2001: Habitat and site affinity of the round goby. Journal of Great Lakes Research 27(3): 329-334
Jensen, P.G.; Curtis, P.D.; Lehnert, M.E.; Hamelin, D.L. 2001: Habitat and structural factors influencing beaver interference with highway culverts. Wildlife Society Bulletin 29(2): 654-664
Litzgus, J.D.; Brooks, R.J. 2000: Habitat and temperature selection of Clemmys guttata in a northern population. Journal of Herpetology 34(2): 178-185
Hampton, R.; Small, E.; Haunold, A. 2001: Habitat and variability of Humulus lupulus var. lupuloides in upper midwestern North America: A critical source of American hop germplasm. Journal of the Torrey Botanical Society 128(1): 35-46
Sukhotin, A.A.; Poertner, H.O. 1999: Habitat as a factor involved in the physiological response to environmental anaerobiosis of White Sea Mytilus edulis. Marine Ecology Progress Series 184: 149-160
Donaldson, T.J. 2002: Habitat association and depth distribution of two sympatric groupers of the genus Cephalopholis (Serranidae: Epinephelinae). Ichthyological Research 49(2): 191-193
Wiley, J.W. 2003: Habitat association, size, stomach contents, and reproductive condition of Puerto Rican boas (Epicrates inornatus). Caribbean Journal of Science 39(2): 189-194
Scales, J.A.; Wilkins, K.T. 2003: Habitat associations and diversity of the rodent community in the Edwards Plateau of Central Texas. Texas Journal of Science ust; 55(3): 201-214
Melville, J.; Swain, R. 1999: Habitat associations and natural history of the Tasmanian snow skinks (Niveoscincus spp.). Papers and Proceedings of the Royal Society of Tasmania 133(1): 57-64
Maravelias, C.D. 2001: Habitat associations of Atlantic herring in the Shetland area: Influence of spatial scale and geographic segmentation. Fisheries Oceanography 10(3): 259-267
May, C.A.; Gutierrez, R. 2002: Habitat associations of Mexican Spotted Owl nest and roost sites in central Arizona. Wilson Bulletin 114(4): 457-466
Russ, J.M.; Montgomery, W.I. 2002: Habitat associations of bats in Northern Ireland: Implications for conservation. Biological Conservation 108(1): 49-58
Sudheendrakumar, V.; Binoy, C.; Suresh, P.; Mathew, G. 2000: Habitat associations of butterflies in the Parambikulam Wildlife Sanctuary, Kerala, India. Journal of the Bombay Natural History Society ust; 97(2): 201
Yoklavich, M.M.; Greene, H.G.; Cailliet, G.M.; Sullivan, D.E.; Lea, R.N.; Love, M.S. 2000: Habitat associations of deep-water rockfishes in a submarine canyon: An example of a natural refuge. Fishery Bulletin (Washington D C) 98(3): 625-641
Robertson, M.S.; Winemiller, K.O. 2003: Habitat associations of fishes in the Devils River, Texas. Journal of Freshwater Ecology ch; 18(1): 115-127
Mueller, K.W. 2002: Habitat associations of introduced smallmouth bass and native signal crayfish of Lake Whatcom, Washington. Journal of Freshwater Ecology ch; 17(1): 13-18
Spina, A.P. 2003: Habitat associations of steelhead trout near the southern extent of their range. California Fish and Game 89(2): 81-95
Teangana, D.O.; Russ, J.M.; Mathers, R.G.; Montgomery, W.I. 2000: Habitat associations of the red squirrel Sciurus vulgaris and grey squirrel S. carolinensis in Northern Ireland. Biology and Environment 100B(1): 27-33
Hanchey, M.F.; Wilkins, K.T. 1998: Habitat associations of the small-mammal community in the grand prairie of north-central Texas. Texas Journal of Science 50(2): 107-122
Powers, S.L.; Jones, G.L.; Redinger, P.; Mayden, R.L. 2003: Habitat associations with upland stream fish assemblages in Bankhead National Forest, Alabama. Southeastern Naturalist 2(1): 85-92
Mac-Nally, R.; Horrocks, G. 2002: Habitat change and restoration: Responses of a forest-floor mammal species to manipulations of fallen timber in floodplain forests. Animal Biodiversity and Conservation 25(1): 41-52
Takeshita, N.; Kimura, S. 1998: Habitat change with growth of the yearlings of the cyprinid fish Hemibarbus barbus in the Chikugo River. Journal of National Fisheries University 47(1): 15-21
Mascitti, V. 2001: Habitat changes in Laguna de Pozuelos, Jujuy, Argentina: Implications for South American Flamingo populations. Waterbirds 24(1): 16-21
Jaggi, C. 1998: Habitat changes, genetic variability, and possible protection measures for the Asp viper, Vipera aspis, in northwestern Switzerland. Mitteilungen der Naturforschenden Gesellschaft in Bern 55: 135-158
Liljaniemi, P.; Vuori, K.-Matti; Ilyashuk, B.; Luotonen, H. 2002: Habitat characteristics and macroinvertebrate assemblages in boreal forest streams: Relations to catchment silvicultural activities. Hydrobiologia 474: 239-251
Powell, A.N. 2001: Habitat characteristics and nest success of Snowy Plovers associated with California Least Tern colonies. Condor 103(4): 785-792
Kroll, A., J.; Boykin, K.; Andersen, M., C.; Thompson, B., C.; Daniel, D., L. 2003: Habitat characteristics of Ashmunella (Gastropoda: Pulmonata: Polygyridae) at White Sands Missile Range and Fort Bliss, New Mexico. Southwestern Naturalist 48(1): 14-22
Riebesell, J., F.; Thrasher, T., L.; Bazzi, A.; Kovalak, W., P. 2001: Habitat characteristics of Rocky Mountain (Colorado) populations of Acroloxus coloradensis. American Malacological Bulletin 16(1-2): 33-40
Wilson, K., W.; Belk, M., C. 2001: Habitat characteristics of leatherside chub (Gila copei) at two spatial scales. Western North American Naturalist 61(1): 36-42
Durner, G.M.; Amstrup, S.C.; Fischbach, A.S. 2003: Habitat characteristics of polar bear terrestrial maternal den sites in northern Alaska. Arctic ch; 56(1): 55-62
Baur, B.; Zschokke, S.; Coray, A.; Schlapfer, M.; Erhardt, A. 2002: Habitat characteristics of the endangered flightless beetle Dorcadion fuliginator (Coleoptera: Cerambycidae): Implications for conservation. Biological Conservation 105(2): 133-142
Corsetti, L. 1999: Habitat characteristics of the spectacled salamander Salamandrina terdigitata (Lacepede, 1788) in southern Latium (Central Italy). Amphibia Reptilia 20(1): 77-82
Poole, J.; Bowles, D., E. 1999: Habitat characterization of Texas wild-rice (Zizania texana Hitchcock), an endangered aquatic macrophyte from the San Marcos River, TX, USA. Aquatic Conservation 9(3): 291-302
Powlik, J.J. 1999: Habitat characters of Tigriopus californicus (Copepoda: Harpacticoida), with notes on the dispersal of supralittoral fauna. Journal of the Marine Biological Association of the United Kingdom 79(1): 85-92
Winkler, C.; Buck, M.; Meister, S. 1998: Habitat choice and population status of amphibia in Westensee (Ostholsteinisches Huegelland, Schleswig-Holstein). Drosera 98(2): 139-150
Carter, K.; Goldizen, A., W. 2003: Habitat choice and vigilance behaviour of brush-tailed rock-wallabies (Petrogale penicillata) within their nocturnal foraging ranges. Wildlife Research 30(4): 355-364
Forstmeier, W.; Bourski, O.V.; Leisler, B. 2001: Habitat choice in Phylloscopus warblers: The role of morphology, phylogeny and competition. Oecologia (Berlin) 128(4): 566-576
Cheney, K.L.; Cote, I.M. 2003: Habitat choice in adult longfin damselfish: Territory characteristics and relocation times. Journal of Experimental Marine Biology and Ecology 287(1): 1-12, 26 February
Zydelis, R. 2000: Habitat choice of Steller's Eider Polysticta stelleri wintering at Lithuanian coast of the Baltic Sea. Acta Ornithologica 35(1): 129-131
Neubauer, W. 1998: Habitat choice of the Common Tern Sterna hirundo in eastern Germany. Vogelwelt 119(3-5): 169-180
Meinig, V.H. 2000: Habitat choice of the sibling species Sorex araneus and S. coronatus (Insectivora, Soricidae) in northwestern Germany. Zeitschrift fuer Saeugetierkunde 65(2): 65-75
Hakkarainen, H.; Mykra, S.; Kurki, S.; Korpimaki, E.; Nikula, A.; Koivunen, V. 2003: Habitat composition as a determinant of reproductive success of Tengmalm's owls under fluctuating food conditions. Oikos 100(1): 162-171
Carter, J.E.; Jones, M.H. 1999: Habitat composition of Mauritius Kestrel home ranges. Journal of Field Ornithology 70(2): 230-235
Gafny, S.; Goren, M.; Gasith, A. 2000: Habitat condition and fish assemblage structure in a coastal mediterranean stream (Yarqon, Israel) receiving domestic effluent. Hydrobiologia 422-423: 319-330
Szankowski, M.; Klosowski, S. 2001: Habitat conditions of the phytocoenoses dominated by Luronium natans (L.) Rafin in Poland. Hydrobiologia 455: 213-222
Beets, J.; Muehlstein, L.; Haught, K.; Schmitges, H. 2003: Habitat connectivity in coastal environments: Patterns and movements of caribbean coral reef fishes with emphasis on bluestriped grunt, Haemulon sciurus. Gulf and Caribbean Research 14(2): 29-42
Appeldoorn, R.; Friedlander, A.; Sladek Nowlis, J.; Usseglio, P.; Mitchell Chui, A. 2003: Habitat connectivity in reef fish communities and marine reserve design in Old Providence-Santa Catalina, Colombia. Gulf and Caribbean Research ch; 14(2): 61-77
Schramm, H., L.,. Jr.;; Eggleton, M., A.; Mayo, R., M. 2000: Habitat conservation and creation: Invoking the flood-pulse concept to enhance fisheries in the lower Mississippi River. Polskie Archiwum Hydrobiologii 47(1): 45-62
Koford, R.; Stallman, H. 2002: Habitat conservation for birds in the Mississippi Headwaters/Tallgrass Prairie Ecosystem. Great Plains Research 12(1): 123-139
Forbes, L Scott; Jajam, M.; Kaiser, G.W. 2000: Habitat constraints and spatial bias in seabird colony distributions. Ecography ober; 23(5): 575-578
Alvarado, M. 2000: Habitat correlates of ant assemblages in different forests of the South Pannonian Plain. TISCIA (Szeged) 32: 35-42
Luttrell, G., R.; Echelle, A., A.; Fisher, W., L. 2002: Habitat correlates of the distribution of Macrhybopsis hyostoma (Teleostei: Cyprinidae) in western reaches of the Arkansas River Basin. Transactions of the Kansas Academy of Science 105(3-4): 153-161
Schindler, D.E.; Scheuerell, M.D. 2002: Habitat coupling in lake ecosystems. Oikos 98(2): 177-189
Roussel, J.M.; Bardonnet, A. 2002: Habitat de la truite commune (Salmo trutta L.) pendant la periode juvenile en ruisseau: Preferences, mouvements, variations journalieres et saisonnieres. Bulletin Francais de la Peche et de la Pisciculture (365-366): 435-454
Klausmeier, C.A. 2001: Habitat destruction and extinction in competitive and mutualistic metacommunities. Ecology Letters uary; 4(1): 57-63
Prakash, S.; de Roos, Aé.M. 2002: Habitat destruction in a simple predator-prey patch model: How predators enhance prey persistence and abundance. Theoretical Population Biology 62(3): 231-249
Casagrandi, R.; Gatto, M. 2002: Habitat destruction, environmental catastrophes, and metapopulation extinction. Theoretical Population Biology 61(2): 127-140
Stiles, G.-Jeffrey; Coyle, F., A. 2001: Habitat distribution and life history of species in the spider genera Theridion, Rugathodes, and Wamba in the great Smoky Mountains National Park (Araneae, Theridiidae). Journal of Arachnology 29(3): 396-412
Beier, U. 2001: Habitat distribution and size structure in freshwater fish communities: Effects of vendace on interactions between perch and roach. Journal of Fish Biology 59(6): 1437-1454
Qu-Yan-Hua; Lei-Fu-Min; Yin-Zuo-Hua 2002: Habitat distribution of snow finches (Montifringilla) in China. Acta Zoologica Sinica 48(4): 471-479
Burcher, C.L.; Smock, L.A. 2002: Habitat distribution, dietary composition and life history characteristics of odonate nymphs in a blackwater coastal plain stream. American Midland Naturalist 148(1): 75-89
Aiken, M.; Coyle, F., A. 2000: Habitat distribution, life history and behavior of Tetragnatha spider species in the Great Smoky Mountains National Park. Journal of Arachnology 28(1): 97-106
Young, K.A. 2001: Habitat diversity and species diversity: Testing the competition hypothesis with juvenile salmonids. Oikos 95(1): 87-93